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1. INTRODUCTION 
 
A key requirement in metazoan development is for cells to communicate with each other.  
As a zygote gives rise to a body of cells that will ultimately make the adult organism, 
groups of cells will acquire distinct fates in order to contribute to distinct organs or 
tissues.  For the various aspects of morphogenesis to occur, cells must remain in constant 
communication with each other, receiving or sending instructive, inhibitory or permissive 
signals.  Given the diversity of biological responses found in cells during the course of 
development   proliferation, differentiation, migration, cell metabolism and cell survival 
to name just a few  it is surprising that the signal transduction pathways that elicit 
unique responses in different target tissues often make use of the same molecules.  Thus, 
the diversity of signals is not paralled by a diversity of molecules.  Furthermore, 
pathways are not linear and extensive crosstalk amongst pathways exists.  One of the 
challenges in understanding signal transduction is to define which components and what 
combinations of crosstalk make each biological response unique. 
The embryo of the fruitfly Drosophila melanogaster provides a well developed 
experimental system to investigate the nature of a signaling event.  In addition to its being 
amenable to genetic dissection, a handful of signaling cascades that have been well 
characterized allow us to address the specificity of a signal in relation to its unique 
biological response.  This is particularly clear in the case of Receptor Tyrosine Kinase 
(RTK) signaling.  Several RTK cascades have been characterized and as mentioned 
above, despite the diverse biological responses, many of their components are shared.  
Thus, all RTKs can activate the Mitogen Activated Protein Kinase (MAPK) cascade via 
the small GTP-binding protein Ras.  The ultimate response elicited by each RTK is, 
however, unique.  It therefore remains to be determined what features of signaling are 
combined to achieve this effect. 
The fibroblast growth factor (FGF) signaling pathways in Drosophila provide a suitable 
system to analyze two well described effects of RTK signaling via the Ras-MAPK 
signaling pathway, namely differentiation and cell movement.  Drosophila is equipped 
with two FGF receptors (FGFRs) called Heartless and Breathless.  Heartless (DFGFR-2) 
is required early in development for the cells of the mesoderm to spread along the lateral 
ectoderm and later for proper differentiation of heart precursors and midline glia cells 
(Shishido et al. 1997; Michelson et al. 1998).  Breathless (DFGFR-1) plays multiple roles 
in the formation of the respiratory system.  It is initially used to establish the tracheal 
branch network and later employed to remodel tracheal branches in response to changes 
in oxygen requirement (Jarecki et al. 1999; Klämbt et al. 1992; Reichman-Fried et al. 
1994).  A subtle role of Breathless in the migration of a subset of glia cells has also been 
described (Klämbt et al. 1992).  While both FGF pathways have been shown to signal 
through Ras, the pathways to their effects are by no means linear and branch points 
remain to be elucidated.  Downstream of FGFR (Dof), a cytoplasmic molecule essential 
exclusively for FGF signal transduction (Imam et al. 1999; Michelson et al. 1998; 
Vincent et al. 1998), lies upstream of the Ras-MAPK pathway and provides an entry 
point into this investigation.  Dof provides us with a signaling component that uses 
common cascades but confers specificity to one type of RTK signal, namely that of the 
FGFR.  The way this large molecule functions is unknown, and one way to gain insight 
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into its function along with defining potential branch points of the pathway is to identify 
interacting partners that are part of the signaling cascade.  In this work, a yeast two 
hybrid screen was conducted to identify such partners. 
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Figure 1.1  This is a figure of the predicted motifs and structures in the Dof protein (transcript II) adapted 
from Vincent et al.  (1998).  The ankyrin repeat is marked by a square and the coiled coil domain by an 
oval.  Vertical bars indicate the position of tyrosines which, when phosphorylated, might be binding sites 
for the proteins indicated above the diagram. 
Dof can be defined as an adaptor molecule because it links upstream and downstream 
molecules of a signaling cascade.  The Dof protein contains an ankyrin repeat and a 
coiled-coil domain, two features which confer Dof with an homology to the vertebrate 
tyrosine kinase substrate BCAP (Okada et al. 2000).  Dof also contains several tyrosines 
within environments that become putative binding sites if the tyrosine is phosphorylated.  
The motifs are shown in Figure 1.1.  However, although Dof is tyrosine phosphorylated 
in the presence of the activated FGFR Breathless in tissue culture, none of the putative 
tyrosines shown in Figure 1.1 is essential on its own for Dof to function (R. Wilson 
personal communication).  Thus, apart from the fact that Dof is required for the 
transduction of signals by FGFRs, and that an artificially activated Ras molecule can 
more or less compensate for its absence, not much else is known about how Dof signals 
and can only be guessed by looking at what is already known about a cell that engages in 
FGF signaling and what goes wrong when this does not occur.  The introduction to this 
thesis attempts to assemble information about signaling pathways and molecules that 
have been characterized in more detail (many reviews are available on this vast topic), 
and hopes to refine the expectations to be put on a molecule whose lack of functional 
structural motifs make it difficult to place in any of the known signaling categories.   
 
1.1 Signal Transduction via Receptor Tyrosine Kinases 
 
Receptor Tyrosine Kinase activation 
 
Receptor Tyrosine Kinases constitute a large group of  membrane spanning cell surface 
receptors that activate cytoplasmic signaling cascades and elicit a diverse range of 
responses in  target tissues (reviewed in Schlessinger 2000 and references therein).  As 
their name suggests, RTKs have intrinsic protein tyrosine kinase activity.  The tyrosine 
kinase is situated in the cytoplasmic domain.  When a ligand binds to the extracellular 
domain of the receptor, it induces receptor dimerization, bringing the protein tyrosine 
kinases of RTK monomers close enough to phosphorylate each other at tyrosine residues 
in the activation loop of the catalytic domain.  Phosphorylation causes the activation loop 
to adopt an open configuration, permitting access of the kinase to ATP and substrates.  
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The active, autophosphorylated receptor dimer transmits the signal in two ways:  First, its 
active kinase can phosphorylate downstream signaling proteins.  Second, the active 
receptor can phosphorylate further tyrosines on its cytoplasmic domain (mostly in the 
noncatalytic regions of the receptor molecule) which thereby become docking sites for 
adaptor molecules, which it can phosphorylate, too.  Other adaptor molecules might be 
constitutively bound to the cytoplasmic domain, and become phosphorylated upon kinase 
activation. 
 
Signaling cassettes activated by Receptor Tyrosine Kinases 
 
Receptor tyrosine kinases activate a number of signaling cascades.  As Figure 1.2 
illustrates, receptor tyrosine kinases activate the Ras MAPK cascade, phospholipase Cγ 
(PLCγ), Phospholipid Kinase (PI3K) and the JAK/STAT pathway and thus activate 
effector molecules in the nucleus or the cytoplasm.  The arrows in this flow chart 
emphasize that the signaling cassettes activated by the receptor tyrosine kinase engage in 
cross talk, thus creating a complex network of stimulatory and inhibitory signals.  The 
activation of the Ras MAPK cascade will be described below in more detail, since it is 
essential for transduction of the FGF signal in Drosophila.  However, this figure is 
intended to expose the scope of  possible signaling pathways that can be used by a 
receptor tyrosine kinase, given the appropriate intracellular domain and the matching 
intracellular proteins to respond to its activated state. 
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Figure 1.2  This figure has been adapted from Schlessinger (2000) and illustrates the various signaling 
cassettes (not all components are included) that have been shown to be activated by RTKs.  The 
autophosphorylated receptor is shown in green and the various signaling casettes are depicted in shaded 
boxes. 
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Receptor Tyrosine Kinase activation of the Ras MAPK cascade 
 
Many cell surface receptors, including all RTKs, stimulate the exchange of GTP for GDP 
on the small G protein Ras.  Ras is activated by the guanine nucleotide exchange factor 
Son of sevenless (Sos), which is constitutively complexed with the adaptor protein Grb2 
via its SH3 domain.  Depending on the receptor, the Sos/Grb2 complex is recruited to an 
activated RTK directly or via intermediate molecules.  The SH2 domain of Grb2 can bind 
to specific phospohotyrosine sites of the receptor and thereby position Sos at the plasma 
membrane, where it is brought into the vicinity of Ras.  Ras is anchored at the inner face 
of the plasma membrane via C-terminal lipid modification (reviewed in Hunter 2000).  
Alternatively, Grb2/Sos can bind to the adaptor protein Shc, which forms a complex with 
many receptors through its phosphotyrosine (PTB) domain.  Another means for activation 
of the Ras MAPK pathway is via the binding of Grb2/Sos complexes to membrane linked 
docking proteins such as insulin receptor substrate-1 (IRS1) or FRS2α, which become 
tyrosine phosphorylated in response to activation of certain RTKs. 
 
Ras activates MAPK cascade and PI3K 
 
The active GTP-bound Ras interacts with several effector proteins.  The best 
characterized effector proteins are Raf and PI(3)K (reviewed in Rommel and Hafen 
1998).  Raf is the protein kinase at the top of the MAPK cascade that leads to the 
activation of ERK (extracellular signal related kinases).  The phospholipids generated by 
activated PI(3) kinases serve as second messengers and recently, distinct binding domains 
for 3-phosphoinositides in diverse range of target molecules have been identified 
(reviewed in Leevers et al. 1999).  One of these bindings domain is the Pleckstrin 
homology (PH) domain,  a module that can regulate a proteins membrane localization in 
response to signaling (see below). 
 
Crosstalk between Ras and RhoGTPases 
 
While many cellular events are affected by Ras GTPases, the Rho family of GTPases is 
considered to be the major orchestrator of actin mediated cytoskeletal changes, and has 
been shown to engage in crosstalk with Ras, namely the Rho family of GTPases 
(reviewed in Hall and Bar-Sagi, 2000).  It has been shown  that Cdc42, a member of the 
Rho family of GTPases, can be activated by Ras, thus providing a link between two 
major signaling pathways. 
 
The highly conserved MAPK cascade  
 
Mitogen-activated protein kinases (MAPK) are the convergence point of a multitude of 
signaling cascades and when activated influence a wide range of cellular processes such 
as metabolism, cell cycle, cell migration, cell shape, cell proliferation and differentiation 
(reviewed in Davis, 2000).  Activated MAPKs can translocate into the nucleus and 
activate transcription factors and phosphorylate effector proteins in the cytoplasm, for 
example  pp90 ribosomal S6 kinase (reviewed in Blenis, 1993). 
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MAPK is the serine-threonine protease at the bottom of a three-member protein 
kinase cascade.  MAPK is activated by MAPK kinase (MAPKK) which in turn is 
activated by a MAPKK kinase.  It is worth noting that the MAPKK kinases, that is, the 
kinases at the top of the modules, have different defined regulatory motifs that are not 
found in MAPKKs or MAPKs, including PH domains, SH3 binding domains, binding 
sites for GTP-binding proteins and phosphorylation sites for tyrosine and serine/threonine 
kinases  indicating that these can be differentially regulated by a variety of upstream 
inputs (Garrington and Johnson, 1999).  The components of this cascade have been 
conserved from yeast to mammals and every eukaryotic organism has multiple MAPK 
pathways, which are largely separate from one another (reviewed inHunter, 2000).  One 
factor that keeps the pathways separate is that the MAPK kinases phosphorylate their 
target MAPKs on conserved threonine and tyrosine residues which are separated by an 
intervening amino acid that is characteristic for each MAPK family.   
Raf is the MAPKKK which activates MEK, a MAPKK.  When MEK activates 
ERK, ERK translocates from the cytoplasm to the nucleus where it  phosphorylates and 
activates transcription factors, for example ternary complex factor  (reviewed in Karin 
and Hunter 1995). 
 
1.2 Protein Modules 
 
A salient feature of signaling molecules, including those that mediate signals from RTKs,  
is that their composition is modular (motifs and sequences are reviewed in Pawson 1995; 
Kuriyan and Cowburn 1997; Pawson and Scott, 1997).  A modular protein is one which 
is made up of several domains, and in a way, each module is an entity on its own.  
Individual modules may have enzymatic properties or a domain that brings about 
interactions with other proteins, phospholipids or nucleic acids.  By having several 
modules, catalysis is separated from target recognition, and target recognition modules 
can be combined in an as yet undefined number of ways.  Modular signaling molecules 
create versatile combinations of input and output signals and it is easy to see how they 
contribute significantly to the branches within complex signaling networks. 
There are two types of modules that bring about interactions with other 
molecules.  Some modules, like Src homology-3 (SH3) domains and some 
phosphotyrosine binding (PTB) domains are the mere plugs and sockets that connect 
parts of a network together.  Other  modules, most prevalently the Src homology-2 (SH2) 
domain and many PTB domains act as sensors of transient states that are manifested in 
nothing more than a phosphorylated tyrosine in the interacting partner.  In other words, 
SH2 domains and many PTB domains only bind to motifs in which the tyrosine is 
phosphorylated.  Other modules, like Pleckstrin Homology (PH) domains regulate the 
proteins localization in the cell in response to signaling.  This section introduces the 
modules have been found in signaling molecules that transmit signals from activated 
RTKs. 
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Domains that mediate binding to an activated RTK 
 
The activated RTK oligomers can phosphorylate tyrosines on target proteins as well as 
tyrosines on itself.  The tyrosines that are phosphorylated on the receptor serve as 
docking sites for SH2 or PTB containing proteins. 
SH2 domains bind to amino acid sequences defined by 1 to 6 residues C-terminal 
to the phosphotyrosine moiety.  One group of SH2 domain containing proteins contains 
intrinsic enzymatic activities that are activated by the RTK merely by it localizing them 
to the membrane via their SH2 domain (as in the case of PI3-K) or by a conformational 
change caused by SH2-domain-mediated binding to the receptor (as in the case of Src). 
SH3 domains are small modules that bind to sequences containing proline 
residues arranged in characteristic PxxP motifs.  Some RTK binding proteins contain 
only SH2 or SH3 domains and appear not to have any enzymatic activity.  Their main 
role is to function as adaptors between molecules.  For example, the adaptor protein Grb2 
links a variety of surface receptors to the Ras/MAP kinase signaling cascade by 
interacting with activated RTKs via its SH2 domain and using its SH3 domain to recruit 
Sos close to its target protein Ras at the cell membrane. 
PTB domains have been found to mediate binding between a RTK and a variety 
of signaling molecules.  In fact, vertebrate FGFRs use PTB containing proteins, not SH2 
domain proteins to recruit the Grb2/Sos complex to the membrane (Klint et al. 1995)  
Most, but not all PTB domains bind to a motif that requires a phosphotyrosine.  For 
example, FRS2, a lipid-anchored docking protein (Kouhara et al. 1997) uses its PTB 
domain to constitutively bind to a the juxtamembrane region of FGFR1 (Xu et al. 1998, 
Ong et al. 2000), but tyrosine phosphorylation is not required, and the minimal sequence 
required for binding does not have any tyrosines (Ong et al. 2000).  In contrast, the same 
PTB domain will bind to a classical NPQpY motif of the nerve growth factor (NGF) 
receptor TrkA (Ong et al, 2000).  As can be seen by the example of FRS2, PTB domains 
are modules with diverse ligand-binding specificities. 
 
Domains that mediate membrane localization 
 
Localization of signaling molecules within the cell is an important feature of signal 
transduction.  Not only can this provide directionality to a signal (as in chemotaxis), but 
some proteins can only function at certain locations in the cell.  Most obviously, proteins 
that activate transcription have to be in the nucleus to function, and cytoplamic anchoring 
is used as a means of regulating their actions.  For example, STAT (signal transducer and 
activator of transcription) resides in the cytoplasm and can only translocate to the nucleus 
once it is phosphorylated by Jak tyrosine kinase (reviewed in Darnell 1996; OShea 
1997).  Other signaling molecules have to be recruited to the plasma membrane in order 
to function.  Some molecules, like Ras proteins are constitutively localized to the plasma 
membrane, whereas others localize to the membrane in response to a signal.  This can be 
achieved by the modification of lipids in a region of the membrane or it can be achieved 
by creating binding sites in proteins that are already at the membrane, a feature that has 
been discussed above: SH2 and some PTB containing proteins translocate to the 
membrane by binding to phosphotyrosine sites in receptors or intermediate molecules. 
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Constitutive membrane localization 
 
Lipid modifications of proteins can lead to their constitutive membrane localization.  
Core signaling molecules such as the Ras proteins are localized to the plasma membrane 
via farnesylation of the cysteine of the C-terminal CAAX motif in combination with 
palmitoylated or polybasic residues (reviewed in Magee and Marshal 1999).  This 
membrane localization is crucial for Ras function.  This is where it is activated by the 
Grb2-Sos nucleotide exchange factor and this is where it activates its downstream targets. 
 
Transient membrane localization 
 
PH (Pleckstrin homology) domains are found in a variety of signaling proteins, including 
certain guanine nucleotide exchange factors (GEFs), phospholipase-C (PLC)γ, and a 
large number of docking proteins (Schlessinger, 2000).  Some PH domains have been 
shown to preferentially bind PI(3,4)P2 and/or PI(3,4,5)P3 over other inositol lipids 
(reviewed in Leevers 1999).  3-phosphoinositides are generated by PI3 kinases and 
different classes of PI3 kinases preferentially phosphorylate different lipids.  When the 
PH domain of a protein binds to a certain inositol lipid, this not only allows its 
translocation to a specific membrane but might also induce a conformational change that 
allows its phophosphorylation by other kinases.  For example, it has been suggested that 
the Akt-kinase PDK1 can only phosphorylate and activate Akt when its conformation has 
been changed by its binding to 3-phosphoinositides (Stokoe et al. 1997, Alessi et al. 
1997).   
 PH modules are especially interesting because they have been implicated in 
directional movement.  This was most clearly shown in Dictyostelium discoideum by 
tagging the PH domain containing proteins like CRAC (cytosolic regulator of adenylyl 
cyclase protein) and Akt with Green Fluorescent Protein (GFP) (Parent et al. 1998; Meili 
et al. 1999), and tracing their intracellular localization upon stimulation with 
chemoattractant.  When stimulation occurs, CRAC-GFP, Akt-GFP as well as plain PH-
GFP, transiently localize to the leading edge (reviewed in Parent and Devreotes, 1999).  
It is thought that the PH domain binds to Gβγ subunits or phosphorylated inositol lipids at 
the inner surface of the plasma membrane. 
 
Docking proteins 
 
Docking proteins are another category of protein that  mediate membrane recruitment of 
signaling proteins stimulated by tyrosine phosphorylation of a receptor (reviewed in 
Schlessinger, 2000).  All docking proteins contain in their N-termini a membrane 
targeting signal like a myristoyl anchor or their own transmembrane domain, but mostly a 
PH domain.  The C-terminus has a large region that contains multiple binding sites for 
the SH2 domains of signaling proteins.  Most docking proteins also contain domains like 
the PTB domain that are responsible for complex formation with a particular set of cell 
surface receptors.  For example, the docking protein FRS2 binds specifically to FGFRs 
and NGRs (see above).   
 
  INTRODUCTION 
 8
Scaffold proteins 
 
Scaffold proteins are signal mediators because they bind to several proteins of a 
particular cascade, thereby providing a fast transmission of a signal and an insulation 
from cross-talk with other signaling molecules.  Thus they provide another means of 
achieving specificity because they not only sequester proteins so that they do not interact 
with other proteins but can also regulate the activity of the proteins to which they bind, 
by for example bringing an enzyme into the vicinity of its substrate.  A well studied 
example is Ste5, from the yeast Saccharomyces cerevisiae (reviewed in Garrington and 
Johnson, 1999).  Three MAPK cascade modules exist in yeast and one of these modules  
transduces the mating response upon pheromone binding to a G-protein-coupled seven 
transmembrane receptor.  The Gβγ subunit complex that is released from the activated 
receptor binds to the scaffolding protein Ste5, which in turn binds to all three components 
of the mating response MAPK module (Ste11, Ste7, Fus3), thus ensuring a rapid 
transmission of the signal and also an insulation from the activation of the other MAPK 
modules.  One of the components, Ste11, is also used in another MAPK module, the high 
osmolarity response pathway, but there it is bound to another scaffold (Pbs2).  Thus, for 
each cellular response there is a defined set of signaling ingredients, and scaffold proteins 
channel right ingredients into the appropriate direction. 
 
1.3 Receptor Tyrosine Kinase  signaling in Drosophila 
 
Several RTKs and their signal transduction pathways have been characterized extensively 
in Drosophila (reviewed in MacDougall and Waterfield, 1996 and Sternberg and 
Alberola-Ila, 1998) and like all organisms, share multiple signaling components.  Two of 
these RTKs are employed for very specific events: Sevenless is involved in photoreceptor 
specialization, and  Torso in terminal structure differentiation.  The Drosophila epidermal 
growth factor receptor (DER) is involved in multiple cellular events, including dorsal-
ventral axis specification and wing-vein formation.  As described earlier on, the two 
FGFRs in Drosophila are required for several processes, including mesoderm and heart 
development (Heartless) and tracheal outgrowth (Breathless). 
All RTKs that have been identified in Drosophila can signal via the Ras-MAPK 
cascade (reviewed in Sternberg and Alberola-Ila, 1998).  While the core of the Ras-
MAPK cascade is used by all RTKs,  each receptor can activate Ras1 via a different set 
of molecules.  Thus, activated Torso, Sevenless and EGFR can activate Ras1 either 
directly by recruiting (and phosphorylating) grb2/drk-sos to its phosphotyrosines or via 
adaptor molecules such as Dos (Herbst et al. 1996, Raabe et al. 1996) and Shp2/Csw 
(Perkins et al. 1992).  Recently, two intermediate molecules have been identified that 
selectively transduce a signal from specific RTKs.  The adaptor/scaffolding molecule Shc 
has been shown to link Torso and EGFR,  but not Sev, to the Ras MAPK pathway 
(Luschnig 2000).  Similarly, Dof has been shown to link both FGFRs to the Ras MAPK 
pathway, but does not function downstream of Torso, Sevenless or DER (Vincent et al. 
1998; Michelson et al. 1998; Imam et al. 1999). 
 A good example of the branching of a signal comes from double-mutant analysis 
of the Torso pathway.  Luschnig et al. (2000)  showed that the signal splits into at least 
three parallel branches, represented by Dos, Drk and Shc.  But the components might 
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cross-talk, since Dos contains putative binding sites for the SH2 domains of Drk and Shc 
(Raabe et al. 1996), although the Drk/Grb2 SH2 domain binding sequence has been 
shown not to be essential in rescue experiments (Allard et al. 1998). 
 
1.4 FGF Signaling in Drosophila 
 
As described at the beginning of this Introduction, the two FGFRs in Drosophila, 
Heartless and Breathless are required for morphogenetic processes involving 
differentiation and cell movement.  They elicit these diverse cellular responses by 
activating the Ras MAPK cascade, a processes which is mediated by the cytoplasmic 
protein Dof.  Whether the FGFRs activate other signaling pathways, and whether Dof is 
required for the transduction of these, is unknown.  In any case, it is unlikely that the 
diverse cellular responses elicited by FGF signal transduction, are performed by a single, 
linear pathway.  The following section aims to portray the two best characterized cellular 
processes in Drosophila that employ FGF signaling, mesoderm development and tracheal 
branch outgrowth.   
 
Early mesoderm development 
 
The mesoderm germ layer of the Drosophila embryo gives rise to somatic and visceral 
musculature, the fat body and heart cell precursors (Bate 1993).  The schematic in Figure 
1.3A is a cross section of a Drosophila embryo whose presumptive mesoderm has just 
invaginated into the interior of the embryo and whose cells are just about to spread along 
the lateral ectoderm into a single layered sheet of cells (Figure 1.3B).  Depending on their 
position along the dorso-ventral and anterior posterior axis, the cells receive instructions 
on their fate. 
 
BA  
 
Figure 1.3  A.  This is a simplified sketch of a cross section of an embryo whose mesoderm anlage has just 
invaginated and has undergone an epithelial to mesenchyme transition.  Dorsal is to the top and ventral is to 
the bottom.  The ectodermal germ layer is shown in blue and arrows indicate the direction in which the 
cells will spread.  B.  This sketch depicts the mesodermal cell layer after it has spread along the lateral 
ectoderm. 
 
FGF signaling, via the FGFR Heartless is required for the mesoderm to spread and later 
for heart cell precursors to differentiate.  The ligand which activates Heartless is 
unknown and  it is unclear what directional cues generate the spreading movement.  The 
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manner in which the cells spread has implications for the mechanisms used by the cells to 
reach their final positions along the ectoderm (Wilson and Leptin 2000).  Experimental 
evidence supports the option in which the flattened layer of mesodermal cells (Figure 
1.3B) is created by cells seeking to maximize their contact with the underlying ectoderm 
from which an instructive signal would be emanating.  An interesting possibility for cells 
to reach out to the ectoderm is by using filopodial extensions to find and contact the 
ectoderm.  Such filopodial extensions have been observed in imaginal disc cells, which 
send out long filopodial extensions towards sources of FGF (RamirezWeber and 
Kornberg, 1999)  
 
Tracheal branch outgrowth 
 
The larval tracheal system is made up of epithelial cells that form a hollow tubular 
network that delivers oxygen to target tissue via passive diffusion.  The tracheal system 
develops from ten metameric tracheal placodes on each side of the embryo which 
invaginate to form tracheal pits.  It is from these sac-like structures that branching 
morphogenesis occurs.  The branched network has been described to form in 3 stages, 
each stage employing distinct cellular and molecular mechanisms to create each 
successive branch (Samakovlis et al. 1996) The branches occurring at the first, second 
and third stage are called the primary, secondary and terminal branches respectively, and 
these stages are depicted in the schematic below (Figure 1.4). 
 
1° 2° 3°
 
 
Figure 1.4  This figure is a schematic of the three stages of tracheal branching that occur from a portion of 
an epithelial sac.  Picture adapted from Metzger et al. 1999. 
 
The first two stages of tracheal branch outgrowth involve a multitude of stereotypic 
genetic programs whereas the third stage, during which terminal branches reach their 
targets, is determined by the oxygen requirement of target cells (Samaklovis et al. 1996).  
The chemoattractant Branchless is required at all stages of branching morphogenesis.  
The gene branchless encodes the FGF ligand for the Breathless receptor.  Branching 
starts when primary and secondary branches respond to the Branchless, which is secreted 
by a stereotypic pattern of ectodermal and mesodermal cells that define the direction of 
branch outgrowth (Sutherland et al. 1996).  The terminal branches are made out of 
cytoplasmic extensions that respond to the the oxygen requirement of target cells.  In 
larvae,  Branchless has been shown to mediate terminal outgrowth to oxygen deprived 
target tissue (Jarecki et al.  1999).   
During tracheal branch outgrowth, the FGF signaling pathway must act at 
different levels.  It is required for sheets of cells to move toward a morphogen (primary 
branches) and also for subcellular portions of the plasma membrane to make extensions 
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toward oxygen deprived tissue (terminal branches).  If such distinct morphogenetic 
events are to be orchestrated by the FGF signaling pathway, its downstream components 
are surely intertwined with a vast number of other cellular events and signals whose 
contributions to the final tracheal tree remain to be elucidated. 
 
1.5 Specific Aims of this thesis 
 
Given the different cellular responses that are triggered by the FGF signal 
transduction pathway in Drosophila, an interesting question that arises is how one signal 
can generate different responses.  One way of answering this question is to look for the 
components of a signaling system and determine how they interact with each other to 
bring about a distinct cellular response.  The adaptor molecule Dof is an essential 
component of the FGF signaling system, and because it is used specifically by FGF 
receptors, makes for an interesting component of the pathway.  In this work, a yeast two-
hybrid screen was conducted to identify interacting partners of Dof. 
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2. RESULTS 
 
In this project, a yeast two-hybrid screen was conducted to identify interaction partners of 
Dof.  The Gal4 DNA-binding domain fused to a C-terminal deletion construct of Dof was 
used to screen an embryonic Drosophila cDNA library for potential binding partners of 
Dof.  Two groups of interacting partners were isolated: those that activated the stringent 
reporter Ade2 and those that only activated the less stringent reporter His3.  Three Ade2 
positive candidates proved to be particularly interesting, namely the FGFR Heartless, the 
SUMOlating enzyme Ubc9, and Dof itself.  These three candidates will be presented in 
detail in Chapters 2.3, 2.4 and 2.5.  The final Chapter, Chapter 2.6 summarizes all the 
other candidates and serves primarily to document the groundwork that was made for 
yeast two-hybrid interacting partners whose involvement in Dof function remains 
unknown. 
 
2.1 Description of components used in the yeast two-hybrid screen 
 
The yeast two-hybrid assay 
 
The yeast two-hybrid system devised by Fields and Song (1989) was used to provide a 
physical environment in which to detect potential interactions involving Dof.  The yeast 
two-hybrid assay takes advantage of the fact that domains of transcription factors are 
modular.  Thus, many transcription factors can be separated into at least two distinct 
functional domains, the activation domain and the DNA-binding domain (Keegan et al. 
1986, Hope et al. 1986).  These two domains can constitute a functional transcriptional 
activator even if they are not covalently attached to each other.  An interaction between 
two proteins can be assayed by fusing one to the DNA-binding domain and the other to 
the DNA-activation domain (Fields and Song 1989).  Upon interaction of the two 
proteins, a hybrid transcription factor is reconstituted and expression of a reporter gene 
linked to the upstream activating sequence is activated.  The yeast two-hybrid system can 
thus be used to clone cDNAs encoding interaction partners of a known protein by 
screening an activation-tagged cDNA expression library.  In the literature, hybrid 
proteins might be referred to as bait, prey, or activation tagged.  These are terms used to 
refer to the various hybrids: proteins fused to the DNA-binding domain are termed bait 
and those fused to the activation domain are activation tagged and when part of a 
cDNA library, collectively called the prey. 
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Components of the Yeast Two-Hybrid system 
 
To screen for cDNAs encoding proteins able to interact with Dof in the yeast two-hybrid 
system, the general scheme outlined in Figure 2.1 was employed.   
 
Gal1-His3
Gal7-lacZ
Gal2-Ade2
DB-DofC
DB-DofC
DB-DofC
AD-candidate
transform with AD-library
1. Select His3+lacZ+
2. Select His3+lacZ+Ade2+
Gal1-His3
Gal7-lacZ
Gal2-Ade2
DB-DofC
DB-DofC
DB-DofC
AD-candidate
AD-candidate
 
 
Figure 2.1  This figure is an outline of the selection strategy used to isolate interaction partners of Dof in 
the yeast two-hybrid system.  On the left, the bait construct DB-Dof∆C does not activate the reporters when 
expressed on its own.  Once co-expressed with another protein that is fused to the activation domain ( AD-
candidate) activation of the reporters will occur if the two fusion proteins interact.   
 
Yeast Strains 
 
The host yeast strain used in this study was PJ69-4A (James et al.  1996).  Like all strains 
engineered for use in the yeast two-hybrid system, PJ69-4A contains inducible promoter 
elements fused to reporter genes, thus providing a detectable response to protein-protein 
interactions.  PJ69-4A carries three chromosomally located reporter genes, each under the 
control of a different Gal4 responsive promoter.  Although all are induced to high levels 
by the transcription factor Gal4, they share a minimum of sequence identity.  This 
reduces the number of promoter-specific false positives.  When this strain is used in a 
yeast two-hybrid screen, a true interaction should activate all three markers.  In practice, 
the His3 nutritional marker and the Escherichia coli lacZ gene are activated more readily 
that the Ade2 nutritional marker.  This means that when using Ade2 to select for 
interactions, one should be aware of the fact that weak interactions might be overlooked 
(Phillip  James, personal  communication; see also Discussion). 
 
Expression vectors  
 
Expression vectors used in the yeast two-hybrid screen 
 
The two fusion proteins used in a yeast two-hybrid assay are generated by two different 
cloning vectors.  For the yeast two-hybrid screen with Dof, the bait vector generates a 
hybrid protein between the DNA-binding domain of Gal4 (pGBD-c(x), James et al.  
1996) and a portion of the Dof protein.  The prey vector (pACT2) contains sequences for 
the Gal4 activation region II (Durfee et al.  1993) fused to a cDNA library generated from 
0-18hr Drosophila embryos. 
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Other expression vectors  
 
Besides pGBD-c(x) and pACT2, other expression vectors were used to assay various 
yeast two-hybrid interactions.  The reader is referred to Appendix I for a documentation 
of the different interaction levels observed by different combinations of expression 
vectors.  All vectors contain a truncated version of the Adh1 promoter sequence, 
providing for constitutive expression of the recombinant hybrid proteins.  All fusion 
proteins should be able to enter the nucleus because of the native NLS present in the 
GAL4 binding domain (Silver et al. 1984) or the SV40 large T antigen nuclear 
localization signal that is fused to activation tagged proteins (Durfee et al.  1993).  Other 
features contained in all vectors are the ColE1 origin of replication and the beta lactamase 
gene for replication and selection in Escherichia coli.  For selection and replication in 
yeast, each vector contains the 2-micron origin and a nutritional marker.  Table 2.1 lists 
the vectors used in this work, the markers they carry, and the vectors from which they 
were originally made. 
 
name of 
vector 
derived from fusion tag eukaryotic 
selection  
reference 
pGAD-C(X) pGAD424 GAL4 AD / LEU2 James  et al. 1996 
pGBD-C(X) pGBT9 GAL4 DB / TRP1 James  et al. 1996 
pGBDU-C(X) pGBT9 GAL4 DB / URA James et al. 1996 
pACT2  GAL4 AD HA LEU2 Durfee et al 1993 
pODB8 pAS2 GAL4 DB HA TRP1 Louvet et al.  1997 
pODB80 pAS2 GAL4 DB / TRP1 Louvet et al.  1997 
 
Table 2.1  Description of vectors used in this project 
 
pACT2 Drosophila embryonic expression library 
 
The cDNA expression library used for the screen was made from mRNA derived from 0-
18 hour embryos (gift from Steve Elledge).  The cDNA pool was selected for transcripts 
greater than 1kb and cloned into the lamda phage vector λACT2 (activation domain, 
Durfee et al.1993) The λACT2 vector is converted from a phage to a plasmid using cre-
lox mediated site-specific recombination.  Thus, pACT2 is the plasmid excised from 
λACT2.  Upon receipt, the Drosophila cDNA library was converted from phage into 
plasmid by subcloning conversion (see Materials and Methods for more details).   
 
DB-DofC: The fusion protein used as bait 
 
Instead of using the complete ORF of Dof as bait in the yeast two-hybrid screen, a C-
terminal deletion of the protein was used.  This is shown in Figure 2.2.  This C-terminal 
deletion, is sufficient to rescue mesoderm and tracheal development in a dof mutant 
embryo (R.  Wilson, personal communication).  This deletion construct fused to the DNA 
binding domain is called DB-DofC and the identical region fused to the Gal4 activation 
domain is called AD-DofC. 
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Figure 2.2  The upper figure is a drawing of the full length Dof protein (transcript II) adapted from Vincent 
et al.  (1998).  The ankyrin repeat is marked by a square and the coiled coil domain by an oval.  Vertical 
bars indicate the position of tyrosines which, when phosphorylated, might be binding sites for the proteins 
indicated above the diagram.  Red squares show two regions with putative PEST sequences (Rogers et al.  
1986).  Red dots are potential SUMOlation sites (Melchior 2000).  The lower figure shows the Dof C-
terminal truncation DofC.  The deleted region is shown in light grey.  E denotes the last amino acid and S 
denotes the first amino acid in the protein sequence 
 
Tests with the DB-DofC construct 
 
Before using a fusion protein as bait in a yeast two-hybrid screen, it is important to 
determine whether it is expressed, show that it enters the nucleus and check that it does 
not autoactivate, that is, activate transcription of reporter genes in the absence of the AD-
hybrid protein.  During initial test work,  we observed that DB-DofC and AD-DofC 
interact in the yeast two-hybrid system.  This provides a control for the behaviour of the 
bait construct, and shows that it is being expressed in Saccharomyces cerevisiae and 
entering the nucleus.  When co-expressed with an empty vector, no reporter activation 
occurs, indicating that DB-DofC does not autoactivate.  Table 2.1 shows the results.   
 
 DB-DofC pGBDU-c(1) 
AD-DofC +++ - 
pGAD-c(1) - - 
 
Table 2.2 The left column lists the activation domain fusion proteins and the top row contains the DNA 
binding domain fusion proteins.  +++ indicates growth on SC-His plates after 2 days at 30°C.   means 
that no growth occurred. 
 
AR2.9: DofC integrated into PJ69-4a 
 
For the yeast two-hybrid screen, the construct encoding DB-DofC was integrated into 
the chromosome of the host strain PJ69-4a.  Two advantages have been observed when 
expressing a fusion protein from a chromosomally integrated construct rather than 
expressing a fusion protein from a plasmid.  Integration of an expression construct 
eliminates plasmid recombination and allows a second construct (in this case, the 
expression library) to be transformed into the strain with a greater efficiency.  The 
chromosomal integration of the Dof bait construct was accomplished by removing the 2-
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micron sequence (origin of replication) from the DB-DofC plasmid and transforming 
pJG69-4a with a linearized plasmid.  Upon selecting for an integrated DB-DofC , the 
only cells that replicate are those in which the cDNA has integrated itself into the 
chromosome, since the 2-micron is absent (see Materials and Methods).  To ensure that 
the integration of the construct did not affect the expression of DB-DofC or of any 
other marker, Dof homodimerization was assayed in 10 of the strains in which integration 
had occurred.  The strain with the highest transformation efficiency and showing the 
strongest activation of the reporter His3 with AD-DofC was chosen to be used in the 
yeast two-hybrid screen.  This strain was called AR2.9. 
 
Autoactivation test for fusion proteins 
All fusion proteins that were made in this project were tested for autoactivation.  For 
example,  if an activation tagged protein was used, it was co-expressed with the empty 
expression vector, pGBDU.  Hereafter, this control test will not be mentioned, unless the 
fusion protein autoactivated. 
 
2.2 Description of the yeast two-hybrid screen 
The yeast two-hybrid screen was carried out in two parts.  Initially, His+lacZ+ activators 
were isolated and characterized.  These candidates were sequenced and placed into 
groups of clones coding for the same gene.  The longest transcript from each group was 
subsequently tested for activation of the Ade2 marker in the second part of the screen. 
 
Selection for activation of His3 and lacZ markers 
 
The Drosophila cDNA expression library (from S.  Elledge, see above) was transformed 
into AR2.9 to yield a total of 1.3X106 transformants.  The transformants were grown on 
SC-ULH medium for 6-7 days, allowing for the growth of His3 positive clones.  Next, 
the transformants were replica plated onto SC-ULH/Xgal plates and allowed to grow for 
2-3 days.  269 colonies positive for His3 and lacZ were streak purified on SC-ULH plates 
and plasmid DNA was subsequently isolated.  The plasmid DNA was checked by 
digesting the DNA with the restriction enzymes EcoRI and XhoI, which separates the 
insert from the vector.  The plasmids were transformed back into AR2.9 to reconfirm the 
interaction.  In parallel, the plasmids were transformed into PJ69-4a/pGBDU (a strain 
carrying an empty expression vector) and tested for autoactivation.  Upon 
retransformation, 128 clones still activated the His3 reporter when co-expressed with DB-
Dof∆C but did not autoactivate.  The 5 prime end of each of these clones was sequenced.  
The sequence data was used to search the databases BDGP, BLAST (see Materials and 
Methods) in order to identify transcripts that code for known genes as well as to identify 
transcripts that were isolated multiple times in the screen.  The sequence data showed that 
the 128 clones consisted of 15 transcripts that were isolated multiple times, and 33 
transcripts that were isolated only once.  The list of these clones is shown in Table 2.3.  2 
single clones were subsequently excluded from further analysis because one sequence 
(i99) contained a chain of  26 GAG triplets and the other clone (i30) was derived from 
mitochondrial 16SRNA.  Thus the final count of his+lacZ+ clones comes to 15 groups 
and 31 single copies. 
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Table 2.3  This table is a list of the transcripts isolated in the yeast two-hybrid screen.  Clones that activate 
the Ade2 reporter are highlighted in yellow.  Information about motifs and homologies is given for genes 
that have not been described by a name in Flybase.(1) The name of the gene is given to clones whose 5 
prime sequence is identical to the transcript of a gene that has been given a name by FlyBase (see Materials 
and Methods) in a FlyBase Report.  Note that this can also be a putative gene that has not been 
characterized in Drosophila but whose sequence annotation is homologous to a gene that has been 
characterized in another species.  (2) CG14206: residues 1127 share 62% amino acid identity with 
residues 3130 of Human 40S ribosomal protein S10 (3) The motif found using the PFAM database (see 
Materials and Methods) is noted here if the transcript has not been given a name by Flybase (4) If the clone 
is identical to an annotated gene from the Genome Annotation Database at Flybase (see Materials and 
Methods), the CG number is listed.  If the clone is not identical to any annotated gene, the genomic 
sequence to which it maps (Adams M.D.  et al 2000) is denoted with an AE number.   
 
motifs (3) or aa homology (2) gene (1) members longest clone CG#/ AE#  (4) 
     
fn3 (3)  21 i119 CG 12340 
 Acon 13 i59 CG 9244 
Human 40S ribosomal protein S10(2)  10 i14 CG 14206 
 dof 9 i28 CG 3375 
  6 i238 CG 2713 
 ubc9 5 i56 CG 3018 
 bap60 5 i133 CG 4303 
 heartless 5 i150 CG 7223 
cyclin domain (3)  4 i220 CG 11525 
 βspectrin 4 i6 CG 5870 
DH domain, PH domain (3)  3 i19 CG 2008 
  3 i159 AE 003492 
  2 i199 CG 10189 
  2 i7 AE003433 
 bip2 2 i163 CG 2009 
 rack1 1 i173 CG 7111 
 sinuous 1 i8 CG 10624 
 GAP69C 1 i51 CG 4237 
 cup 1 i239 CG 11181 
 PP2A B 1 i234 CG 7913 
 msl-1 1 i94 CG 10385 
 hr39 1 i70 CG 8676 
 Dmzimp 1 i184 CG 8068 
 haywire 1 i50 CG 8019 
 RpA-70 1 i164 CG 9633 
 not 1 i155 CG 4166 
 BC 1 i12 CG 5779 
 Eps - 15 1 i31 CG 16932 
ankyrin repeats, zinc finger (3)  1 i115 CG 17492 
WD40 domains (3)  1 i207 CG 14805 
 acGAP 1 i249 CG 13345 
zinc finger, C2H2 type (3)  1 i36 CG 11762 
BTB/POZ domain (3)  1 i188 CG 11275 
ABC transporter (3)  1 i17 CG 12703 
 Hsc70-4 1 i190 CG 4264 
SPRY domain (3)  1 i25 CG2944 
Acetyl-CoA hydrolase (3)  1 i130 CG 7920 
  1 i118 AE 003512 
  1 i136 CG 10671 
  1 i175 CG 15740 
  1 i182 CG 14939 
  1 i232 AE 003809 
  1 i169 AE 003512 
  1 i176 AE 003633 
  1 i226 CG 4147 
  1 i187 no hits 
  1 i99  
  1 i30  
 
  RESULTS 
 18
Selection of Ade+ interactions 
 
In the final round, all candidates that activated the His3 reporter were co-expressed with 
DB-Dof∆C to test whether the interaction was strong enough to activate the Ade2 
reporter, which has the most stringent promoter of all three reporter genes (see above).  
Eight groups and 4 single clones activated Ade2.  The clones that activated the Ade2 
reporter are highlighted in Table 2.3 and the co-expressions are shown in Figure 2.3. 
 
Binding of candidates to full length Dof and to a Dof deletion construct  
 
All candidates were tested for activation of the His3 reporter when co-expressed with the 
full length Dof construct and the deletion construct 430, which does not rescue Dof 
function in dof mutant embryos (R.  Wilson, personal communication).  These results are 
shown in Appendix II. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3  In this figure, candidates from the yeast two-hybrid screen were co-expressed with DB-Dof∆C.  
The control in all cases is the empty vector pGBDU co-expressed with i150.  The only difference between 
this test and the test documented in Table 2.3 is that here, a plasmid-borne DB-Dof∆C is used in the co-
expression experiment whereas the tests for activation of the His3 reporter (summarized in Table 2.3) were 
carried out with the construct DB-Dof∆C that was integrated into chromosomal DNA.  This might be the 
reason for the fact that the clones i173 and i163 dont activate His3 when co-expressed with the plasmid-
borne DB-Dof∆C.  Plates on which the interacters grew on SC-ULH but not on SC-ULA are not shown.  
Method used for dot assay: A single colony was inoculated in selection liquid medium (in which the 
presence of the plasmid is selected) and grown at 30°C for 24 hours.  1µl from a dilution series was 
pipetted onto selection plates as indicated.  The pictures were taken after plates were incubated for 5.5 days 
at 30°C.   
  RESULTS 
 19
        
i119
i59
i14
i28
i238
i56
i133
i150
control
i220
i6
i19
i159
i199
i7
i163
i173
control
i115
i36
i12
i30
i8
i136
i187
control
i207
i70
i184
i50
SC-UL SC-ULH SC-ULA
0.10.010.001 0.10.010.001 0.10.010.001
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2.3 Heartless 
 
Five transcripts corresponding to the intracellular domain of Heartless were isolated in 
the screen.  The sequence data showed that all transcripts are in-frame fusions with the 
Gal4 activation domain.  Figure 2.4A shows the positions of the first amino acid of each 
clone in relation to the amino acid sequences of Heartless, Breathless and FGFR1.  The 
longest transcript, i150, contains the whole intracellular domain of Heartless.  The 
shortest transcript, i79, contains only two thirds of the protein kinase domain and shows 
that only the C-terminal part of the intracellular domain of the Heartless receptor is 
essential for binding to Dof∆C.  The crystal structure of the cytoplasmic domain of 
human FGFR1 (Mohammadi et al.  1996) is depicted by a ribbon diagram in Figure 2.4B 
and 2.4C.  Assuming that the structures of Heartless, Breathless and FGFR1 are 
conserved,  the structure of FGFR1 can be used to illustrate the regions of the Heartless 
that are contacting Dof.  The longest clone, i150, contains both lobes of the intracellular 
domain and the shortest clone, i79, only contains the bottom lobe. 
 
Breathless binds to Dof in the yeast two-hybrid system 
 
As mentioned in the Introduction, it has been genetically shown that Dof lies downstream 
of both known Drosophila FGF receptors, namely Heartless and Breathless.  However, 
only transcripts of Heartless were isolated in this screen.  In order to test whether Dof 
also interacts with Breathless in the yeast two-hybrid system, the cDNA corresponding to 
minimal Heartless sequence that binds to Dof (that is, construct i79) was cloned into 
yeast two-hybrid vectors.  The construct is called Btl-K   
 
SC-UL SC-H SC-ULA
0.001 0.01 0.1 0.001 0.01 0.1 0.001 0.01 0.1
growth after 5.5 days at 30°C
DB-Dof∆C i150
pGBDU i150
DB-Dof∆C AD-Btl-K
DB-Dof∆C i79
pGBDU AD-Btl-K
pGBDU i79
DNA
Binding
Domain
Activation
Domain
 
 
Figure 2.5  The activation domain fusion with Breathless (AD-Btl-K) activates the reporter His3 when co-
expressed with DB-Dof∆C.  However, like the equivalent sequence of Heartless (i79), AD-Btl-K does not 
activate the Ade2 reporter when co-expressed with Dof∆C.  In contrast, the longest sequence of Heartless 
isolated in the screen (i150) does activate Ade2 when co-expressed with Dof∆C.  See Figure 2.3 for 
description of dot assay. 
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Figure 2.4  A is an alignment of cytoplasmic domains of FGFR-1 with Heartless and Breathless and arrows 
point to the first amino acid of each transcript isolated in the yeast two-hybrid screen. The Helix and Beta-
sheet positions are for FGFR-1 and taken from Mohammadi et al. 1996. DFGFR-1: Breathless;DFGFR-2: 
Heartless; The amino acid sequence of DFGR-2 is deduced from CT39172. B and C are ribbon diagrams of 
the cytoplasmic FGFR1 structure, which does not include the juxtamembrane region and the last few 
residues of the C-terminus (adapted from Mohammadi et al. 1996). The a helices are shown in red, the b 
strands in green, the nucleotide-binding loop in orange, the catalytic loop in blue, the activation loop in 
yellow, the kinase insert in black, and the side chains of Tyr-653 and Tyr-654 in purple. In B, the region 
that is colored is equivalent to that encoded by i79, the shortest Heartless transcript isolated in the yeast 
two-hybrid screen. 
 
As Figure 2.4A shows, the construct Btl-K contains most of the protein kinase domain 
but lacks the ATP binding region.  The co-expression of AD-Btl-K with DB-DofC 
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resulted in an activation of His3, but not of Ade2 (Figure 2.5).  However, i79, the 
equivalent Heartless construct does not activate the Ade2 either.  This result shows that 
although only Heartless was isolated in the yeast two-hybrid screen, DofC binds to 
Breathless as well in the yeast two-hybrid system. 
 
The cytoplasmic domain of Heartless only interacts with Dof in one direction 
Only  the activation-tagged cytoplasmic domain of Heartless interacts with DB-DofC 
(Figure 2.6).  The Gal4 DNA-binding domain fusion with cytoplasmic Heartless (DB-
Htl) does not activate His3.  One reason for this may be that several intracellular receptor 
domains are brought together at the Gal4 DNA binding sites, resulting in their 
autophosphorylation.  It is therefore conceivable that Dof does not bind to the 
phosphorylated receptor and only binds to the unphosphorylated receptor, because when 
the activation domain is fused to the cytoplasmic domain of Heartless, this domain can 
bind to Dof.  This idea is supported by the fact that the Breathless construct DB-Btl-K 
weakly activates His3 (Figure 2.6).  DB-Btl-K only contains two thirds of the protein 
kinase domain and does not contain the ATP-binding site.  Thus, this construct doesnt 
have a functional kinase domain and when the DB-Btl-K fusion proteins are brought 
together at the Gal4DNA binding sites, they cannot phosphorylate each other. 
 
SC-H SC-UL
SC-WL
SC-UL
growth after 5 days at 30°C
DB-Dof∆C i150
i150
AD-Dof∆C
AD-Btl-KDB-Dof∆C
pGBDU
DB-Btl-K
DNA
Binding
Domain
Activation
Domain
DB-Htl
AD-Dof∆C
0.001 0.01 0.1 0.001 0.01 0.1
 
 
Figure 2.6  The cytoplasmic domain of Heartless only interacts with Dof∆C when it is fused to the 
activation domain (i150).  When it is fused to the DNA-binding domain (DB-Htl) it does not activate His3 
when co-expressed with Dof∆C.  When a short version of cytoplasmic Breathless, which lacks the ATP 
binding site, is fused to the DNA binding domain and co-expressed with Dof∆C, slight activation is 
observed.  See Figure 2.3 for description of dot assay. 
 
i79 and AD-Btl-K behave similarly with the Dof deletion panel 
 
The Breathless construct AD-Btl-K was tested against a panel of Dof deletions to 
determine whether it behaved similarly to i79, the shortest Heartless construct.  Similarly, 
the full length cytoplasmic domain of Heartless was tested against the Dof deletion panel.  
These tests are shown in  Figure 2.7. 
AD-Btl-K and i79 have the same binding behaviour with Dof.  Interestingly, unlike 
construct i150 (the full cytoplasmic domain of Heartless), i79 and Btl-K do not interact as 
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strongly with full length Dof as they do with some of the deletions.  Furthermore, DB430, 
containing a deletion in Dof which abolishes its binding to i150, still shows weak 
interaction with i79 and Btl-K.   
 
Full length Dof binds to the full length cytoplasmic domain of Heartless (i150) but its C-
terminus appears to diminish the strength in binding because when the co-expression with 
i150 is tested for the activation of Ade2 (the more stringent reporter), the full length Dof 
construct does not activate Ade2 transcription, but Dof∆C does.  More than half the Dof 
molecule can be deleted from the C-terminus without affecting its binding to Heartless 
(construct 405).  However, sequences in the N-terminal half are required for binding to 
Heartless because large deletions (DB354, DB264) as well as internal deletions (DB430) 
affect binding.  DB427 represents the largest N-terminal deletion that will still interact 
with Dof.  However, this statement is only partly valid, since DB427 is deleted at the C-
terminus as well, and was used here because the construct with the C-terminus auto-
activates.   
 
A single amino acid change abolishes the interaction between Dof and the FGFRs 
 
As can be seen in Figure 2.7, deletions of portions of the Dof N-terminus diminish its 
ability to bind to the full cytoplasmic domain of Heartless (i150).  In fact, a single amino 
acid exchange, namely from a Lysine to an Arginine at residue 296 in Dof, completely 
abolishes binding of Dof to all the receptor constructs (i150, i79 and Btl-K) when assayed 
for activation of the His3 reporter.  This is shown in figure 2.17 in Chapter 2.5.  The 
lysine that was mutated is a potential SUMO acceptor site, indicating that either 
SUMOlation of Dof is required for interaction with the full cytoplasmic domain, or that 
the Lysine to Arginine mutation resulted in a structural change of the receptor binding 
site.  In the least, this Lysine has been shown to be essential for the interaction of Dof 
with the FGFRs in the yeast two-hybrid system. 
 
Oddly, the minimal receptor constructs (i79 and AD-Btl-K) do still activate the His3 
reporter when co-expressed with Dof molecules that lack the potential SUMO acceptor 
lysine (constructs 430 and 264).  This contradicts the observation that a single amino acid 
exchange in this region abolishes binding of Dof with the receptors.  This might point to 
structural changes that have occurred due to the lack of a SUMOlation site or the 
substitution of Lysine for Arginine. 
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Figure 2.7  This figure shows the interaction of the FGFR constructs (i150, i79 and AD-Btl-K) with a 
panel of Dof deletion constructs. The interaction was assayed with the reporters His3 (top row of pictures) 
and Ade2 (bottom row of pictures). The Dof deletion constructs are drawn here with deleted regions shaded 
in grey (see Materials and Methods for more details and Figure 2.1 for a description of motifs). The 
drawings of the FGFR constructs also show which part of the receptor sequence is included in the 
construct. The circle shows the position of the transmembrane domain of the receptors.  See Figure 2.3 for 
description of dot assay. As a control, all co-expressions were simultaneously tested on SC-UL selection 
plates. All co-expressions grew, but the data is not shown here. 
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2.4 Dof 
 
Nine Dof transcripts were isolated in the yeast two-hybrid screen.  Sequence analysis of 
the 5 prime end showed that all transcripts are in-frame fusions with the Gal4 activation 
domain.  The protein sequences of the longest and shortest transcript are aligned with that 
of full length Dof in Figure 2.8 
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Figure 2.8   This figure shows Dof∆C aligned with the shortest (i21) and longest (i28) Dof transcript 
isolated in the yeast two-hybrid screen.  Areas shaded in light grey indicate regions that are absent from the 
protein.  E denotes the last residue and S denotes the first residue in the protein sequence.  See Figure 2.2 
for a description of motifs. 
 
None of the nine transcripts isolated in the yeast two-hybrid screen code for the full 
length Dof protein, each lacking sequence from the N-terminus.  Figure 2.9A illustrates 
the interaction between Dof∆C and the shortest Dof transcript isolated in the screen. 
 
i21
Dof∆C Dof∆C
Dof∆C
A B
 
 
Figure 2.9  A.  Interaction data from the yeast two-hybrid screen show that an N-terminal deletion of Dof 
can interact with a C-terminal deletion of Dof.  B.  Two C-terminal deletion constructs of Dof can interact 
in the yeast two-hybrid system 
 
In a separate set of experiments, co-expression of AD-Dof∆C and DB-Dof∆C in the yeast 
two-hybrid system resulted in the activation of all three reporters, His3, lacZ and Ade2, 
and indicated that the C-terminal deletion of Dof also binds to itself in the yeast two-
hybrid system.  This is illustrated in Figure 2.9B.  These yeast two-hybrid interactions 
provide potential clues as to how Dof might be functioning in its natural environment.  
One hypothesis is that Dof functions as a homodimer.  A second hypothesis (which does 
not exclude the former hypothesis) is that intramolecular interactions between distinct 
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domains of Dof regulate its behaviour.  For example, the affinity of Dof to other binding 
partners might be modulated by changing conformations via intramolecular interactions. 
 
Mapping the dimerization domains in Dof 
 
In order to determine which regions of Dof interact, a panel of Dof deletion constructs 
was cloned into the yeast two-hybrid expression vectors pGAD and pGBDU/pGBD, such 
that each deletion construct could be expressed as an activation domain fusion protein or 
as a binding domain fusion protein.  As an example of a co-expression, Figure 2.10 
depicts full length Dof fused to the Gal4 DNA-binding domain and full length Dof fused 
to the Gal4 activation domain. 
 
AD256
DB256
Gal4 DNA Binding Domain
Gal4 Activation Domain
 
 
Figure 2.10  This figure is an example two constructs used in a co-expression experiment.  Here, one full 
length Dof transcript is fused to the Gal4 DNA-binding domain sequence and another full length Dof 
transcript is fused to the Gal4 activation domain.  In the pGBDU/pGBD-pGAD vectors used for these 
assays, all constructs will have the fusion moiety at the N-terminus. 
 
Method used for scoring an interaction between two deletion constructs 
 
Pairs of deletion constructs were co-expressed in PJ69-4A and tested for activation of the 
His3 reporter after growth on SC-His agar plates for four and a half days at 30°C.  Since 
different rates of growth were observed, the activation of the His3 reporter was scored in 
the following manner: If co-expression led to colonies as large as those observed with 
Dof∆C dimerization (AD-Dof∆C + BD-Dof∆C), then the interaction was scored as a +.  
If co-expression led to colonies smaller than Dof∆C dimerization but larger than the 
negative control (Dof∆C + empty AD vector) it was scored with a +.  If there was no 
difference between the co-expression culture and the negative control, then this co-
expression was scored as a 0.  Figure 2.11 shows a picture of a typical co-expression 
experiment and the scores that each co-expression would have received.   
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Figure 2.11  How co-expressions were scored in this experiment.  See text for details 
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Figure 2.12  This figure shows all the constructs that were used to establish regions of Dof that are 
homodimerizing.  Areas shaded in light grey indicate regions that are absent from the fusion protein.  E 
denotes the last amino acid in a sequence, S denotes the first amino acid in a sequence, and D denotes the 
first and last amino acid deleted from an interior region.  Note that all constructs were cloned into the 
pGBDU/pGBD-pGAD vectors, except for i28, which is in the vector pACT.  See materials and methods for 
cloning details and Figure 2.2 for a description of motifs. 
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Figure 2.12 lists the Dof deletion constructs used for the domain mapping experiment.  
The figure organizes the deletion constructs into five categories: Full length, N-terminal 
deletions, C-terminal deletions, N-and C- terminal deletions, and internal deletions.  The 
results of co-expressing these constructs are shown in Table 2.3 and the results will be 
discussed below. 
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p 
G 
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D 
256 + +  + + 0 + + +   + + 0 + +  + 0 + 0 0
265 + + + + + 0 + + + 0 0 0 +  + +  0  + 0 0
341 / / / / / / / / / / / / / / / / / / / / / +
404 / / / / / / / / / / / / / / / / / / / / / +
405 + + + + + 0 + + + +  0 + 0 + + + 0 + +  0
340 0 0   0 0       0 0      0  0
352 + +   +  +             0 0 0
353 / / / / / / / / / / / / / / / / / / / / / +
354 + +   +    +           + 0 0
264  +   +     +          + + 0 
16/13  0         +           0
426 + +   0       0        0 0 0
427 +    + 0       + 0     + + 0 0
409C 0    0 0       0 0 + +  0  0 0 0
409 + +   +         + + +  +  0  0
403C + +   +         0 0 +      0
403 / / / / / / / / / / / / / / / / / / / / / +
430C 0 0   0         0 0   0  0  0
430 +    +   +     +      0 0  0
DBi21 0 + + + + 0 0 0 0 0 + + 0 0 0 + 0 0 0 0 0 0
i21cc 0 +   0  0 0 0  0 0 0 0      0 0 0
pGBD 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0
 
Table 2.3  This table shows the scores given to the activation of His3 upon co-expression in PJ694a of two 
Dof fusion proteins containing the series of deletions depicted in Figure 2.12.  The first column (shaded 
blue) contains the name of the construct cloned into the DNA-binding domain vector and the top row 
(shaded yellow) lists all constructs cloned into the activation domain vector.  See materials and methods for 
cloning details.  The green boxes marks the co-expression of an identical construct.  If the construct 
autoactivates, the co-expression is marked with a /.  All other scores are described in Figure 2.11. 
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Interpretation of the Co-expression of Dof deletion constructs 
 
Before the interpretation is presented, two limitations of the yeast two-hybrid system in 
characterizing an interaction should be pointed out.  First if two proteins interact in one 
orientation, they might not interact when they are in the other orientation.  For example if 
a protein interacts with Dof as a DNA binding domain fusion, it might not interact with 
Dof as an activation domain fusion.  This phenomenon was observed several times in the 
co-expression experiments done here (see for example construct 403C and construct 409 
co-expression).  Second, identical proteins expressed from different vectors will exhibit 
different binding behaviour and the construct i21 which was isolated in the yeast two-
hybrid screen, does not interact very strongly with Dof∆C when expressed from the 
pGBDU/pGAD vector series, which was used to express all the deletion constructs (see 
Appendix I).  Thus it is important to keep in mind that besides structural changes might 
be caused by deleting large regions of the Dof molecule, yeast-two hybrid interactions 
can only be interpreted to a certain point. 
 
 Any Dof molecule containing DR#1 homodimerizes 
 
Construct 405 codes for the N-terminal third of Dof.  This construct self-associates and 
defines an N-terminal region that can homodimerize.  For this discussion, the region 
spanning amino acids 1-453 will be defined as Dimerization Region #1 (DR#1).  The 
interaction datum predicts that any Dof molecule containing DR#1 will homodimerize.  
This is illustrated in figure 2.12A.  Table 2.4 highlights all co-expressions that confirm or 
contradict this hypothesis. 
 
DR#1
DR#1
A Bm#1
m#1
 
 
Figure 2.12 
 
The next step is to narrow down the dimerization region of DR#1 by examining the 
behaviour of constructs containing deletions in DR#1.  The construct 430C is as long as 
Dof∆C, but is missing amino acids 233-634.  Whereas Dof∆C dimerizes, construct 430C 
does not.  Construct 430 allows to define a module m#1 (residues 361-441) within 
DR#1 that is required for DR#1 dimerization (Figure 2.12B).  It remains to be seen 
whether module m#1 can dimerize on its own.  This would prove that it is this region 
alone that is mediating the dimerization of DR#1.  Table 2.4 highlights supporting and 
contradicting results.  Note that construct 340 is even shorter than DR#1 and does not 
homodimerize but will be excluded from this analysis since there is no evidence that this 
construct is being expressed ( it does not interact with any other construct).   
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 1,2 1 1 1 1  2 2 2 2     2  2  2 2   
m1 256 1,2 + +  + + 0 + + +   + + 0 + +  + 0 + 0 0
m1 265 1 + + + + + 0 + + + 0 0 0 +  + +  0  + 0 0
m1 341 1 / / / / / / / / / / / / / / / / / / / / / +
m1 404 1 / / / / / / / / / / / / / / / / / / / / / +
m1 405 1 + + + + + 0 + + + +  0 + 0 + + + 0 + +  0
0.5 
m1 
340  0 0   0 0       0 0      0  0
m1 352 2 + +   +  +             0 0 0
m1 353 2 / / / / / / / / / / / / / / / / / / / / / +
m1 354 2 + +   +    +           + 0 0
0.5 
m1 
264 2  +   +     +          + + 0 
0.5
m1 
16/
13 
  0         +           0
m1 426  + +   0       0        0 0 0
m1 427  +    + 0       + 0     + + 0 0
 409
C 
 0    0 0       0 0 + +  0  0 0 0
 409 2 + +   +         + + +  +  0  0
m1 403
C 
 + +   +         0 0 +      0
m1 403 2 / / / / / / / / / / / / / / / / / / / / / +
 430
C 
 0 0   0         0 0   0  0  0
 430 2 +    +   +     +      0 0  0
 i21 2 0 + + + + 0 0 0 0 0 + + 0 0 0 + 0 0 0 0 0 0
 i21
cc 
 0 +   0  0 0 0  0 0 0 0      0 0 0
 pG
BD 
 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0
 
Table 2.4  This table contains the same data as Table 2.3, but highlights the co-expressions that support the 
hypothesis that any Dof molecule containing DR#1 will homodimerize.  Co-expressions in support of this 
hypothesis are coloured in red: +.  Dof deletion constructs that only need module m#1 in DR#1 to 
homodimerize are coloured in turquoise:  + .  Co-expressions shaded in grey are those that contradict the 
model in one direction.  Co-expressions shaded in grey stripes are those that contradict the model in both 
directions.  Additional columns / rows are included here to point out which constructs contain the domains 
m#1 (called m1 here), DR#1 and  DR#2 (called  1 and 2 here). 
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Any Dof molecule containing DR#2 will bind to any Dof molecule containing DR#1 
 
Construct AD/DBi21 codes for the C-terminal third of the Dof molecule and binds to 
construct 405.  Construct DB/ADi21 codes for residues 649-1011 and defines the 
Dimerization Region#2 (DR#2).  DB/ADi21 does not bind to itself, but binds to any 
construct that contains DR#1.  On the basis of these results, two further statements can be 
made: Any molecule containing DR#2 will bind to any Dof molecule containing DR#1.  
DR#2 on its own, however, is not sufficient for dimerization (Figure2.13).  Results 
confirming or negating these statements are highlighted in Table 2.5. 
 
m#1 Hd#2
m#1 Hd#2
 
 
Figure 2.13 
 
Is m#1 the same module within DR#1 that is binding to DR#2? This is very likely since 
403C does not bind to i21, whereas the neighboring deletion, 430C, does bind to DB/AD 
i21.  Put together, the model predicts that the Dof molecule will self-associate because 
m#1 is required for DR#1 to bind to itself and to DR#2.  The model is shown in Figure 
2.14. 
 
m#1 Hd#2
m#1 Hd#2
 
 
Figure 2.14 
 
The putative SUMOlation site in m#1 is not required for Dof self-association 
 
Since it has been observed that SUMO moieties homodimerize in yeast (see Chapter 2.5), 
and since the third putative SUMOlation site is located in the region m#1, the hypothesis 
that Dof might dimerizes because it is SUMOlated, was tested.  However, when this site 
was mutated, the molecules still dimerized (Figure 2.16, Chapter 2.5), thus excluding the 
possibility that homodimerization is mediated by a SUMOlation of Dof at its third 
putative SUMOlation site. 
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 i21
cc 
 0 +   0  0 0 0  0 0 0 0      0 0 0
 pG
BD 
 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0
 
Table 2.5  Coexpression results supporting the hypothesis that any Dof deletion construct containing DR#2 
will bind to any Dof deletion construct containing DR#1 are coloured in red: + The co-expressions 
shaded in dark grey contradict the hypothesis.  Co-expressions supporting the hypothesis that any Dof 
deletion construct containing DR#2 will bind to any Dof deletion construct containing m#1are coloured in 
brown:  + .  Co-expressions shaded in light grey dont fit the aforementioned hypothesis.  The co-
expressions that show that DR#2 is not sufficient for dimerization are coloured in pink:  0 .  Additional 
columns / rows are included here to point out which constructs contain the domains m#1 (called m1 
here), DR#1 and  DR#2 (called  1 and 2 here). 
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2.5 DmUbc9 
 
Five transcripts from Drosophila ubiquitin-conjugating enzyme 9 (DmUbc9) were 
isolated in the screen.  Sequence analysis of the 5 prime end of each clone showed that all 
are in-frame fusions with the Gal4 activation domain.  The longest transcripts, i77 and 
i105 are one amino acid shorter than the full length DmUbc9 and the shortest transcripts 
are 5 amino acids shorter than the full length DmUbc9 protein sequence.  DmUbc9 is 
synonymous with lesswright, abbreviated as lwr.  DmUbc9 encodes a SUMO-conjugating 
Enzyme.  SUMO (small ubiquitin-related modifier) is a member of the family of 
ubiquitin-related proteins and, in contrast to ubiquitin,  has been implicated in the 
regulation of protein-protein interactions and subcellular localization (reviewed in 
Melchior, 2000).   
 
DmUBC9
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i105
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i57
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i147
Ubiquitin-conjugating enzyme
Ubquitin-conjugating enzymes active site
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Figure 2.15  This figure shows the full length protein encoded by DmUbc9 (from the accession number 
AB017607) aligned with the predicted amino acid sequence of the transcripts isolated in the yeast two-
hybrid screen.  The motifs shown in DmUBC9 are names of PFAM motifs (see Materials and Methods) 
scoring higher than gathering threshold.  Note that the longest clones are i105 or i77.  However, in all 
assays, the clone i56 was used to represent this group and thus  misnamed the longest clone. 
 
Dof as a potential SUMO target 
 
The minimal consensus sequence for SUMOlation is aKX(E,D)  (Melchior, 2000) and 
Dof has four Lysines that could potentially serve as an acceptor site for the SUMO 
protein (Figure 2.16). 
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Figure 2.16  This is a picture of full length Dof (see Figure 2.2 for details and motifs) which points out the 
four putative SUMOlation sites and the PEST sequence. 
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Another feature that Dof shares with SUMO targets is its PEST sequence.  When 19 
verified SUMO targets were examined (Melchior 2000),  10 contained one or more PEST 
sequences. 
   
Mutation of the third putative SUMOlation site in Dof 
The third putative SUMOlation site in Dof (at residues 296  299) is located in a region 
of the molecule that when missing, affects Dofs in vitro and in vivo behaviour.  When 
this region is deleted (D233-449), as for example in construct 430C, dimerization no 
longer occurs (Table 2.3).  When D233-449 is deleted from the full length molecule 
(construct 430), interaction with some of the yeast two-hybrid candidates is compromised 
or does not occur at all anymore (Appendix II).  Above all, construct 430 does not rescue 
the Dof mutant phenotype in the mesoderm and the trachea (R.Wilson, personal 
communication).  Since yeast SUMO self-associates (I.  Schwienhorst, personal 
communication), it is possible that if the third putative SUMOlation site in Dof is indeed 
SUMOlated, Dof dimerizes because of the SUMO moieties attached to it.  In order to test 
this hypothesis, the third SUMOlation site in Dof was mutated by exchanging the Lysine 
(K297) for an Arginine.  When a protein becomes SUMOlated, the COOH-group of the 
C-terminal Glycine of SUMO becomes covalently bound to the epsilon NH3-Group of 
the Lysine in the SUMOlation motif (reviewed in Melchior 2000).  The SUMOlation site 
mutation was introduced into the Dof∆C construct in order to assay dimerization of the 
N-terminal region Hd#1 without the disturbance of the C-terminus (region Hd#2) to 
which Hd#1 can also bind (see Chapter 2.4 for details).  The construct was called 
∆s.site3.   
 
+++ ++++++ 0DB-s.site3
AD-s.site3 DofC i150 DB430
IKCE
DofC
IRCE
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430
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Figure 2.16  B shows the results for the activation of the reporter His3 by co-expression of the constructs 
shown in A.  +++ = same growth as AD-Dof∆C + DB-Dof∆C co-expression after 4.5 days at 30°C on SC-
H selection plates. 
 
When co-expressed, DB−∆s.site3 and AD-∆s.site3 still activated the His3 reporter 
(Figure 2.16), indicating that if the third putative SUMOlation site were SUMOlated, it 
would not be the cause of the interaction between Hd#1.  Surprisingly, the ∆s.site3 
construct did not interact with the Heartless receptor construct i150.  When DB−∆s.site3 
was co-expressed with the other Ade+ candidates, interaction of the His3 reporter was not 
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compromised for any of them, other than for the two FGFRs (Figure 2.17).  It should be 
noted that while the interaction of Dof∆C and i56 (the transcript coding for the AD-Ubc9 
fusion protein) is diminished (Figure 2.17), this is not due to the mutation in the putative 
Lysine acceptor site, since ∆s.site3 still binds strongly to i56.   
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Figure 2.17  This figure shows the co-expression of the Ade+ candidates with either DB-Dof∆C or DB-
∆s.site3 on SC-H selection plates.  For comparison, co-expression data of DB-430 (depicted in Figure 2.16) 
with the Ade+ candidates (Appendix II.) was included in the right column of the table.  See Figure 2.3 for 
description of dot assay. 
 
Expression pattern of DmUbc9 and analysis of DmUbc9 mutants 
The i56 transcript, visualized by a Dig-labeled probe, is found ubiquitously at early 
stages but by stage 17 is restricted to the nervous system (Figure 2.17).  The cytological 
location of DmUbc9 is at 21C5-6.  The DmUbc9 mutant phenotype has been described 
(Epps and Tanda 1998) and has been shown to block nuclear import of the transcription 
factor Bicoid, resulting in multiple defects in anterior segmentation.  The development of 
the tracheal system in embryos which lack DmUbc9 (listed in Table 2.6) was examined 
by staining the tracheal lumen with the antibody mAB2A12.  Stage 15-16 embryos were 
evaluated.  No gross defects in tracheal development were observed.  Thus, the dorsal 
trunk was fused, the dorsal, visceral and ganglionic branches were normal present.  
Embryos carrying the p-element insertion lwr02858 were stained with anti-Evenskipped to 
mark a subset of heart precursor cells which are absent in dof mutant embryos.  Embryos 
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from P{ry+t7.2=PZ}lwr02858 cn1/CyO;ry506 parents showed a normal pattern of 
Evenskipped expressing cells.  It is still possible that a maternal contribution of DmUbc9 
is present in the DmUbc9 homozygous mutant embryos and that defects in tracheal 
development or mesoderm migration could therefore not be determined. 
 
Figure 2.17  The expression pattern of DmUbc9 (visualized with Dig-labeled i56 anti-sense RNA) in wild 
type embryos that are approximately at the developmental stage 9 (A), 14 (B) and 17 (C).  Staging 
according to Campos-Ortega, J.A.; Hartenstein, V.  1997.  Embryos are shown from the lateral view.  
Anterior is to the left, posterior to the right.   
 
B# genotype description of mutagen 
11214 P{ry+t7.2=PZ}lwr02858 cn1/CyO;ry506 P-element P{PZ} inserted 560 bp downstream of 
putative polyadenylation signal for lwr (1) 
11410 P{ry+t7.2=PZ}lwr05486 cn1/CyO;ry506 P-element P{PZ} inserted into 5UTR of lwr (1) 
3548 Df(2L)al, dsal/In(2L)Cy, Cy1 Breakpoints: 021B08-C01;021C08-D01, 022D01-
02;033F05-034A01 (2) 
3084 Df(2L)ast2/SM1 Breakpoints: 021D01-02;022B02-03 
 
Table 2.6 This table lists the mutant DmUbc9 Drosophila strains that were used to analyze embryos 
lacking DmUbc9.  B#: Bloomington Stock Center stock number (1) Epps and Tanda  1998, Spradling et al. 
1999 (2) Lindsley and Zimm 
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2.6 Further yeast two-hybrid interacting partners of Dof  
 
As mentioned at the beginning of the results section, this chapter serves to document the 
investigations made with the other yeast two-hybrid partners of Dof.   
 
(Ade+) Interacting partners implicated in cytoskeletal functions 
 
Three candidates isolated in the yeast two hybrid screen are potentially mediators of 
cytoskeletal functions, namely βSpectrin, and Sinuous and the i19 group (i19).  These 
will be presented in this sub-chapter. 
 
βSpectrin 
 
Transcripts corresponding to βSpectrin were isolated four times in the yeast two-hybrid 
screen.  Sequence analysis of the 5 prime end shows that the longest transcript, i6, 
contains the last three spectrin repeats and the PH domain of beta-spectrin.  The other 
three clones are just one amino acid shorter than i6.  All four clones code for an in-frame 
fusion protein.  βSpectrin is a component of the spectrin-based membrane skeleton, 
which confers mechanical stability to the membrane by being anchored to transmembrane 
proteins and to the actin cytoskeleton (Bray, 2000).  βSpectrin associates with αspectrin 
to form a heterotetramer. 
 
βSpectrin
i6
i168, i86, i18
aa1823
aa1824Calponin homology (CH) domain
Spectrin repeat
PH domain
2291aa
 
 
Figure 2.18  This figure shows the full length protein βSpectrin (sequence taken from the accession 
number AAA28399.1) aligned with the predicted amino acid sequences of the transcripts isolated in the 
yeast two-hybrid screen.  The motifs shown in βSpectrin are names of PFAM motifs (see Materials and 
Methods) scoring higher than gathering threshold.   
 
Expression Pattern of βSpectrin and analysis of βSpectrin mutants 
 
Figure 2.19 shows embryos stained with Dig-labeled βSpectrin.  The βSpectrin transcript 
is expressed ubiquitously until about stage 14.  Then, high levels of transcript are found 
in the visceral mesoderm (A and B) , the central nervous system (C and D), the hindgut 
(F) and the posterior spiracles (E). 
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Figure 2.19  The expression pattern of βSpectrin (visualized with Dig-labeled i6 anti-sense RNA) in wild 
type embryos that are approximately at the developmental stage 11 (A,B), 14 (C-F).  Staging according to 
Campos-Ortega, J.A.; Hartenstein, V.  1997.  Anterior is to the left, posterior to the right, A and C are 
lateral views, B,D,E and F are dorsal views.   
 
The cytological location of βSpectrin is16C1.  Table 2.7 shows the mutant strains used to 
analyze mesoderm and tracheal development in embryos lacking βSpectrin.  Embryos 
were stained with the antibody mAB2A12 which marks the tracheal lumen and with anti-
Evenskipped to mark a subset of heart precursor cells which are absent in dof mutant 
embryos.  Stage 15-16 embryos were evaluated.  No gross defects in tracheal 
development were observed and all three strains showed a normal pattern of even skipped 
expressing cells.  Thus, if βSpectrin is required for Dof function, then the maternal 
contribution of βSpectrin is compensating for the lack of a zygotic transcript, or it has a 
redundant function, or it is required in other tissues in which Dof functions but that 
werent analyzed here. 
 
BL# genotype description of mutagen 
4953 Df(1)BD10, r* f1/DP91;Y)W73/C(1)DX breakpoints: 16A2;16C7-10,15C1-
D6;16F;Yh1-h26 
 Beta Spectrin em21/FM7 GFP Ethyl-Methyl-Suffocate (1) 
 Beta Spectrin em6/FM7 GFP Ethyl-Methyl-Suffocate (1) 
 
Table 2.7 This table lists the mutant βSpectrin Drosophila strains that were used to analyze embryos 
lacking βSpectrin.  B#: Bloomington Stock Center stock number (1) Gift from R.  Dubreuil 
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Sinous 
The transcript i8 was isolated once in the screen and the 5 prime end is identical to 
CG10624, an annotated sequence on the third chromosome (64D3-4) showing no 
significant homology to any known gene.  A P-element in the strain l(3)06524 is inserted 
at position 301 of the CG10624 open reading frame.  The mutation arising from the 
insertion of the P-element l(3)06524 has been called sinuous and was identified in a 
screen for tracheal tube expansion mutants (Beitel et al.  2000).  The insertion affects 
both tube length and tube diameter, resulting in enlarged and convoluted tracheal tubes 
(the dorsal trunk follows a tortuous path because it is too large) that are often constricted 
at fusion points. 
 
The transcript of i8 is not in frame with the Gal4 activation domain.  A new construct was 
made in which the reading frame was adjusted (construct 308) to code for the same 
amino acids encoded by the open reading frame of CG10624.  This construct, however, 
did not activate the reporter His3 when co-expressed with Dof∆C.  This result will be 
discussed with the other candidates from the screen that were out of frame with the 
activation domain (see Discussion) 
 
An alignment of the predicted amino acid sequence of i8 with that of CG10624 is shown 
in Figure 2.20.  The amino acid sequence of an in-frame i8 transcript is 19 amino acids 
short of the predicted protein sequence of CG10624.  The 3 end of i8 contains an exon 
not included in CG10624, but the  additional sequence shows no homology to anything in 
the database and no motif for the translated sequence was found in PFAM.  A PFAM 
motif search with CG10624 revealed a similarity (albeit below gathering threshold) to the 
PMP22_Claudin domain.  Proteins with the PFAM PMP22-Claudin domain (accession 
number PF00822) are integral membrane proteins of about 200 residues.  They have four 
conserved transmembrane regions and are localized to tight junctions, the vertebrate 
equivalent of Drosophila septate junctions.  A search for transmembrane regions (TM 
PRED, ISREC Server) in the predicted protein sequence of CG10624 predicts 4 
transmembrane regions having a strongly preferred intracellular N-terminus.   
 
i8
286aa
CG10624
transmembrane region
PMP22-Claudin domain
aa267
 
 
Figure 2.20 This figure shows the predicted amino acid sequence for the predicted gene CG10624, also 
called Sinuous (sequence taken from the open reading frame of CG10624) aligned with the predicted amino 
acid sequence of i8 (using the same reading frame as that of CG10624).  The PMP22-Claudin domain 
shown in Sinuous is a PFAM motifs (see Materials and Methods) scoring lower than gathering threshold.  
The transmembrane regions were predicted by the program TM PRED 
 
The in situ hybridization with Dig-labeled antisense i8 RNA in Figure 2.21 shows that 
sinuous is expressed in the ectoderm (A,B) in the hindgut (C), but is absent from the 
ventral ectoderm.  The ectodermal expression is not uniform.  Higher expression levels 
can be seen in a segmental pattern (A, B, E).  At later stages, the transcript is found in the 
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dorsal branch, but this might be background staining, since the staining is found in the 
lumen and not in the cells. 
 
 
 
Figure 2.21  This figure shows the expression pattern of sinuous (visualized with Dig-labeled i8 anti-sense 
RNA) in wild type embryos that are approximately at the developmental stage 9 (A), 14 (B-E) and 17 
(D,F).  Staging according to Campos-Ortega, J.A.; Hartenstein, V.  1997.  Anterior is to the left, posterior 
to the right, A and B are lateral views, C,D and F are dorsal views, E is a ventral view.  D is a higher 
magnification of the posterior dorsal trunk in F. 
 
 
i19 
 
The group i19 consists of three members.  All three clones code for an in-frame fusion 
protein.  Part of the 5 prime end of the three clones matches the predicted gene CG2008 
whose protein sequence contains two PH domains and a Dbl homology (DH) domain 
(Figure 2.22).  As can be seen in Figure 2.22,  additional 5 prime sequence is contained in 
the i19 transcripts, suggesting that the annotated gene CG2008 does not reflect the entire 
gene coding for the i19 group transcripts.  Further sequence analysis of the longest clone, 
i19, showed that the 3 prime and 5 prime sequence of i19 is contained in the expressed 
sequence tag (EST) SD10794, whose sequence encompasses two annotated sequences, 
CG2008 and CG1288.  The protein sequence of CG1283 contains a FERM domain (4.1  
ezrin  radixin  moesin domain).  The clone SD10794 was sequence and compared to 
other available sequences in this region.  The results are summarized in Figure 2.23 and 
the predicted borders of each exon are listed in Table 2.7. 
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Guanine nucleotide exchange factor for
Rho/Rac/Cdc42-like GTPases
Also called Dbl-homologous (DH) domain
PHdomain
i19
i108
i23
CG2008 (561aa)
 
 
Figure 2.22 This figure shows the full length protein encoded by CG2008 aligned with the predicted amino 
acid sequence of the transcripts of the i19 group.  The motifs shown in CG2008 are names of PFAM motifs 
(see Materials and Methods) scoring higher than gathering threshold.  Note that all three clones contain 
additional sequence at the 5 end. 
 
1kb
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Figure 2.23 This figure is an alignment of the sequence of SD09116 and SD10794,  CG1283, CG2008 and 
i19 on the genomic sequence SEG: AE003604.  The predicted exons are shown as brown boxes.  For each 
sequence analyzed, dashed lines indicate regions that werent sequenced, whereas filled lines indicate 
regions for which sequence data is available.  Numbers on top of each filled line indicate the approximate 5 
prime and 3 prime position on the genomic sequence to which the sequence matches.   
 
exon 5 prime 3 prime sequence data 
1 199358 199876 i19, SD10794 
2 201 505 202 107 CG2008, SD10794 
3 202506 203 654 CG2008, i19, SD10794 
4 218 552 218 814 i19, SD10794 
5 218 878 218 998 i19, SD10794 
6 219241 219347 SD10794 
7 220 730 221 138 SD09116.3prime 
8 221 038 221 145 CG1283 
9 221 192 221 362 CG1283, SD09116.3prime (3 only) 
10 221 411 221 663 CG1283,  
11 221 713 221 946 CG1283, SD10794.5prime (5 only) 
12 222 060 666 304 CG1283, SD10794.5prime 
13 226 756 227 019 CG1283, SD10794.5prime 
14 227 453 227498 SD09116.5prime (5 only) 
15 233 768 234 317 SD09116.5prime 
 
Table 2.7 lists the approximate beginning and end of each putative exon in the region AE003604 and the 
sequence data used to map these positions.   
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Motifs in SD10794 and its homology to CDEP 
 
The sequence analysis of SD10794 shows that it encodes a protein with a FERM domain, 
a Dbl homology (DH) domain and two PH domains.  When the sequence of SD10794 is 
compared to other sequences in the database (search method used: TBLASTX), it shows 
high homology (E-value e-174) to human CDEP (chondrocyte derived ezrin protein).  
CDEP was isolated using the subtractive hybridization method between dedifferentiated 
cartilage cells and overtly differentiated cartilage cells (Koyano et al. 1997).  As 
suggested by the high homology to SD10794, CDEP also contains a FERM domain,  a 
PH domain and a DH domain.  All three domains are implicated in cytoskeletal functions.  
FERM domains are found in a number of cytoskeletal-associated proteins that associate 
with various proteins at the interface between the plasma membrane and the cytoskeleton 
(Chishti AH et al.  1998).  Rho guanine nucleotide exchange factors convert the inactive, 
GDP-bound Rho to active, GTP-bound Rho, and thus regulate the activity of the small 
GTPase Rho.  Rho family GTPases are considered to be a major regulator of actin 
mediated cytoskeletal changes (reviewed in Hall and Bar-Sagi, 2000).  PH domains, as 
discussed in the Introduction, potentially mediate membrane localization of proteins in 
response to signaling.   
 
i19 expression pattern and analysis of Deficiencies  
 
At stage 10, the i19 transcript is expressed in the somatic and head mesoderm, as well as 
at the hindgut invagination.  At stage 14, the transcript is found in many tissues, including 
the visceral mesoderm, the head mesoderm, the hindgut and, possibly the tracheae. 
 
 
Figure 2.23  This figure show the expression pattern of  i19 (visualized with Dig-labeled i19 anti-sense 
RNA) in wild type embryos that are approximately at the developmental stage 9 (A, B), and 14 (C,D) 
Staging according to Campos-Ortega, J.A.; Hartenstein, V.  1997.  Embryos are shown from a lateral view 
in A and C and from a dorsal view in B and D.  Anterior is to the left, posterior to the right.   
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One way to establish whether gene i19 is involved in the same signaling cascade as Dof 
is to determine whether i19 is also required in tracheal morphogenesis or mesoderm 
spreading by analyzing an embryo that lacks i19.  Ideally, the gene would be disrupted by 
a point mutation or a transposon insertion, but no such mutation has been recorded in 
Flybase.  The i19 transcript locates to position 82E on the cytological map.  The closest 
mapped P-element insertions are in the gene corto at 82F5 (EP(3)0775) and in CG14656 
at 82E1 (l(3)02733 and EP(3)3416).  The relatively small deficiency, Df(3R)107, 
removes the genomic region at 82E01-3.  This deficiency has been shown by 
complementation analysis to delete the genes opa, Gnf1, l(3)82Ea and l(3)82Eb (Flybase, 
Megraw and Cook, 1998.10.2) but does not delete corto or l(3)02733.  Using the genomic 
sequence and the aforementioned complementation analysis, it is possible to limit the 
deleted region of Df(3R)107 down to a maximum of 18 annotated genes (including 
CG2008 and CG1283), two of which have been described, namely opa and Gnf1. 
 Although Df(3R)107 removes i19, it is not possible to use this deficiency strain to 
analyze the phenotype of a loss of i19 since the gene opa, which is also removed, disrupts 
the orderly development of segment polarity, thus obfuscating any phenotype caused by 
the loss of i19.  l(3)82Ea and l(3)82Eb (Flybase, Megraw and Cook, 1998.10.2) are two 
strains containing lethal mutations which map to this region.  Since the two lethal 
mutations map to the same region as i19, there was a possibility that these mutations 
disrupt i19.  The mutant embryos from heterozyogous l(3)82Ea and l(3)82Eb parents 
were examined by staining the tracheal lumen with the antibody mAB2A12, marking a 
subset of heart precursor cells with anti-Evenskipped and marking the visceral mesoderm 
with anti-FasciclinIII.  Neither mutant allele showed an abnormal phenotype.  The 
deficiencies and lethal alleles that were analyzed are listed in Table 2.8. 
 
BL# Genotype comments 
BL76 w*; Df(3R)107, e*/TM3, P{w+mW.hs=Thb8-lacZ}WD1, Sb1 
Ser1 breakpts082E01-03;082E01-03  
pair-rule segmentation defects (due to opa) 
BL4841 w1118; l(3)82EaT6/TM6B, Tb1 wild type trachea 
BL4810 l(3)82Eal18/TM3, Sb1 wild type trachea after rebalancing 
BL4811 l(3)82EbT10 eT10/TM6B, Tb1 wild type trachea 
BL4812 l(3)82EbT47/TM3, Sb1 messy embryos possibly due to balancer 
 
Table 2.8  This table lists the mutant Drosophila strains that were used to analyze embryos lacking the 
gene coding for i19.  B#: Bloomington Stock Center stock number  
 
In summary, the genetic analysis of embryos lacking the gene coding for i19 was not 
completed.  All deficiency chromosomes in this region remove odd paired, and therefore 
cannot be used to determine whether the lack of i19 disrupts the same developmental 
processes in which Dof is involved.  l(3)82Ea and l(3)82Eb are two lethal mutations 
which map to this region (complementation analysis).  Since the two lethal mutations 
map to the same deficiency as i19, it was possible that these mutations disrupt i19.  
However, neither mutant strain showed any abnormal phenotype in the tissues assayed.  
This leaves the following possibilities if i19 were to affect the same functions as Dof: the 
two lethal strains are lethal mutations in genes different from i19, the maternal 
component might compensate for the lack of zygotic i19 and finally, i19 might affect 
other morphogenetic process in which Dof is involved but were not assayed here. 
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Other Ade+ Interacting partners 
 
In this section, all interaction partners that are not described above and that activated the 
Ade2 reporter when co-expressed with Dof∆C are described here.  The clone i136 (whose 
5 prime sequence matches that of the predicted gene CG10671) is not described here 
since it was not analyzed further. 
 
i7  
 
The group i7 consists of two clones.  The transcript maps to SEG: AE003433 and maps 
cytologically to 4D2-F2.  Sequence analysis of the 5 end of transcripts i7 and i104 shows 
no homology to any known expressed sequence tag or annotated sequence, nor does the 
predicted protein sequence have any PFAM motifs.  No mutations in this gene have been 
recorded and no embryos in which this gene is removed were analyzed.  The expression 
pattern of the gene coding for i7 is shown in Figure 2.24.  The i7 transcript can be 
detected in the ectoderm at early stages and in the central nervous system and tracheal 
lumen at later stages (C,D,E,F,G).   
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Figure 2.23  This figure show the expression pattern of  i7 (visualized with Dig-labeled i7 anti-sense RNA) 
in wild type embryos that are approximately at the developmental stage 7 (B), 9 (A) 16 (C,D) and 17 
(E,F,G) Staging according to Campos-Ortega, J.A.; Hartenstein, V.  1997.  Embryos are shown from a 
lateral view in A,B,C and E and from a dorsal view in D and F.  G is a higher magnification of the dorsal 
branch in F.  Anterior is to the left, posterior to the right.   
 
i159  
 
The group i159 consists of three identical clones.  The transcript maps to SEG: 
AE003492 and maps cytologically to 11F-12A.  Sequence analysis of the 5 end of 
transcripts i159 shows no homology to any known expressed sequence tag or annotate 
genes, nor does the predicted protein sequence have any PFAM motifs.  The expression 
pattern of the gene coding for i159 is shown in Figure 2.24 and shows that it is expressed 
ubiquitously at early stages but becomes restricted to the central nervous system at later 
stages. 
 
 
 
 
 
Figure 2.24  This figure show the expression pattern of  i159 (visualized with Dig-labeled i159 anti-sense 
RNA) in wild type embryos that are approximately at the developmental stage 11 (A), 14 (B,C) and 15 (D) 
Staging according to Campos-Ortega, J.A.; Hartenstein, V.  1997.  Embryos are shown from a lateral view 
in A,B and D and from a ventral view in C.  Anterior is to the left, posterior to the right.   
 
Embryos deficient for the genomic region 11F-12A from parents of the strains listed in 
Table 2.9 were examined by staining the tracheal lumen with the antibody mAB2A12 and 
marking a subset of heart precursor cells with anti-Evenskipped.  All embryos had wild 
  RESULTS 
 46
type trachea and normal Evenskipped expressing heart precursor cells.  The deficiencies 
and lethal alleles that were analyzed are listed in Table 2.8. 
 
BL# genotype comments 
966 Df(1)N12, ras1v1/FM6 breakpoints 11D1-2;11F1-2 
967 Df(1)C246/FM6 11D-E;12A1-2 
 
Table 2.8  This table lists the mutant Drosophila strains that were used to analyze embryos lacking the 
genomic region 11F  12A.  B#: Bloomington Stock Center stock number 
 
Haywire 
 
The transcript i50 was isolated in the yeast two-hybrid screen as a single clone.  Sequence 
analysis of the 5 prime end of the clone showed that the transcript is from the gene 
haywire, which encodes a general RNA polymerase II transcription factor (Figure 2.25).  
The haywire cDNA in construct i50 is not in frame with the Gal4 activation domain. 
 
Helicase conserved C-terminal domain
i50
CG8019
aa333
798aa
 
 
Figure 2.25  This figure shows the predicted amino acid sequence encoded by haywire (CG8019) aligned 
with the predicted amino acid sequence of i50 (using the same reading frame as that of haywire).  The 
motifs shown in CG8019 are names of PFAM motifs (see Materials and Methods) scoring higher than 
gathering threshold 
 
The expression pattern of haywire is shown in Figure 2.24 and shows that it is expressed 
ubiquitously at all stages. 
 
 
 
 
 
 
Figure 2.26  This figure show the expression pattern of i50 (visualized with Dig-labeled i150 anti-sense 
RNA) in wild type embryos that are approximately at the developmental stage 11 (A,B) and 14 (C,D).  
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Staging according to Campos-Ortega, J.A.; Hartenstein, V.  1997.  Embryos are shown from a lateral view 
in A,B and C and from a dorsal view in D.  Anterior is to the left, posterior to the right.   
 
Mutations in haywire exist and have been described.  For the analysis here the deficiency 
Df(3L)lxd6, in which haywire is deleted, was used to determine whether the lack of 
haywire might affect tracheal development or mesoderm migration.  The deficiency 
y[1?];Df(3L)lxd6/TM3, Sb[1] Ser[1] has its breakpoints between 067E01-02 and 
068C01-02.  As can be seen if Figure 2.27, the tracheae do not develop as in wild type 
embryos: all branches develop except for the dorsal branch.  The subset of heart 
precursor cells which do not develop in dof mutant embryos do develop normally in these 
embryos.   
 
 
 
Figure 2.27 This figure shows an embryo from parents of the genotype y[1?];Df(3L)lxd6/TM3, Sb[1] 
Ser[1].  The embryo in A is stained with the antibody mAB2A12, which marks the tracheal lumen.  
Embryos in B and C are stained with mBA2A12 (in brown) and anti-Evenskipped (in blue), which marks a 
subset of heart precursor cells.  Embryos are shown from a lateral view in A and B and from a dorsal view 
in C.  Anterior is to the left and posterior is to the right. 
 
Hr39 
 
The transcript i70 was isolated once in the yeast two-hybrid screen.  DNA sequence 
analysis of the 5 prime end showed that i70 is a transcript of Hormone receptor-like in 39 
(Hr39), also known as FTZ-F1β, which encodes an orphan member of the nuclear 
receptor superfamily (Ayer et al.  1993; Ohno and Petkovich 1993).  Hr39 is synonymous 
with CG8676 and its gene product codes for a nuclear receptor.  The transcript i70 
encodes an in-frame fusion with the Gal4 activation domain and the i70 transcript codes 
for a protein that starts at the equivalent of amino acid 446 of Hr39.  An in situ 
hybridization with dig-labeled i70 shows that Hr39 is expressed in the ectoderm (Figure 
2.28). 
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ligand-binding domain of nuclear
hormone receptor
C4-type steroid
receptor zinc finger
CG8676
808aa
aa446
 
 
Figure 2.27  This figure shows the predicted amino acid sequence encoded by Hr39 (CG8676) aligned 
with the predicted amino acid sequence of i70.  The motifs shown in CG8676 are names of PFAM motifs 
(see Materials and Methods) scoring higher than gathering threshold 
 
 
 
 
 
A
C
E
D
F
B
 
 
Figure 2.28  This figure show the expression pattern of i70 (visualized with Dig-labeled i70 anti-sense 
RNA) in wild type embryos that are approximately at the developmental stage 10 (A, B), and 14 (C-F) 
Staging according to Campos-Ortega, J.A.; Hartenstein, V.  1997.  Embryos are shown from a lateral view 
in A and C and from a dorsal view in B and F and from a ventral view in E and D.  Anterior is to the left, 
posterior to the right.   
 
The cytological position of Hr39 is 39C1-4.  A P-element insertion in Hr39 exists and is 
called Hr39k13215.  The P-element insertion maps to the first intron but does not affect 
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viability.  Whether the P-element insertion generates a null allele of Hr39 is unclear, 
since residual Hr39 expression could be detected in a Northern Blot of mRNA from 
Hr39k13215 embryos (Thummel, D.I.S.80, 1997).  Df(2L)TW1/CyO is a deficiency strain 
in which the region 038A07-B01 to 039C02-03 is deleted.  This deficiency was initially 
used to determine whether the absence of i70 leads to a disruption in tracheal 
development.  However, the deficiency removes the EGFR ligand Spitz, and EGF 
signaling is required during tracheogenesis (Wappner et al.  1997, Llimargas and 
Casanova 1999).  The trachea of these embryos do not develop normally (Figure 2.29) 
and the phenotype of the deficiency is as strong as that of embryos that are hemizygous 
for Spi2A14 and Df(2L)TW1/Cyo, indicating that the severe phenotype found in 
Df(2L)TW1/Cyo embryos is due mainly to the absence of Spitz. 
 
Df(2L)TW1/Cyo Df(2L)TW1/Cyo
Df(2L)TW1/Spi2A14 Df(2L)TW1/Spi2A14
A B
C D
 
 
Figure 2.29 This figure shows embryos stained with mAB2A12, an antibody which marks the tracheal 
lumen.  The two embryos Spi2A14 flies were a provided by S.  Roth.  The embryos in B and D are arrested 
in germ band extension and the embryos in A and C are at about stage 14. 
 
i14  
 
The interactor group i14 contains 10 members.  Sequence analysis of the 5 prime end 
shows that the transcript derives from the gene predicted by CG14206.  The amino acid 
sequence of CG14206 is homologous to human rpS10.  The sequence analysis of the 5 
prime end of i14 members revealed two further features.  First of all, all the transcripts 
are out of frame.  That is, were the reading frame of the Gal4 activation domain upheld, 
only a few codons would code for an amino acid, before the first stop is encountered.  
None of the interactors contain the reading frame that would give rise to the CG14206 
protein, in fact, four clones are in the +2 reading frame, and the other 6 are in the +3 
reading frame.  The second observation is that all clones contain the 5 UTR.  This is 
shown in Figure 2.30 
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694bp
CG14206
reading frame = +2:
reading frame = +3:
i73
i179
i162
i14
i102
i134
i22
i69
i139
i3
ATG (reading frame = +1)
 
 
Figure 2.30  The DNA sequence of CG14206 is shown aligned to the transcripts from the i14 group.  The 
open reading frame of CG14206 is shown by an arrow.  Clones that are in the +2 reading frame are 
shown in green and clones that are in the +3 reading frame are shown in red. 
 
The longest clone in the i14 group is i73 and its 5 prime end is identical to the expressed 
sequence tag cDNA LP04523.  The sequence CG14206 maps to the position 18D7 on the 
first chromosome.  There are no recorded deletions in this region.  The sequence of 
CG14206 is highly homologous to CG12275.  Which maps to the position 98B on the 
third chromosome.  There are two P-element strains that have an insertion in CG12275, 
namely one at base 417 (EP(3)3203) and the other at base 249 (EP(3)3683).  The trachea 
of embyros homozygous for each insertion were examined using the lumenal marker 
mAB2A12, but no obvious defects were observed. 
 
Candidates that activate the His3, but not the Ade2 reporter 
 
The candidates that did not activate the Ade2 reporter when co-expressed with Dof∆C are 
listed in Figure 2.31.  The Figure includes the deficiency strains analyzed to determine 
whether the lack of a certain gene disrupts tracheal development or mesoderm migration 
(see figure legend for more details).  Appendix III reports the analysis of the group i119, 
which was analyzed in detail because the deficiency strain which removes this region 
showed a strong phenotype.  However, when a mutation was made in the gene 
corresponding to the i119 group, the tracheal development was found to be normal. 
 
 
 
 
Figure 2.31  This figure lists the clones that did not activate the Ade2 reporter when co-expressed with 
Dof∆C.  The columns contain the following information  1. the position of the first base of the candidate 
clone that matches the full length cDNA (CG annotated genes were used for this figure).  2.  here it is noted 
whether the transcript is in-frame with the activation domain fusion protein.  3.  The length of the cDNA 
sequence used in column 4.  4. A figure of the cDNA sequence (thin bar), the open reading frame (thick 
bar) and PFAM motifs (squares or rectangles).  The sequence contained in the interacting candidates is 
shaded in grey and if more than one candidates belong to a group, the first base of the shortest clone is 
indicated by an arrow.  5.  This column gives the name of the gene and the CG annotated sequence used for 
this figure 6.  Cytology 7.  Bloomington number of Deficiency analyzed 8.  Genotype of Deficiency 
analyzed 9.  Comments about Deficiency analyzed. 
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3. DISCUSSION 
 
Vertebrate FGFRs activate the Ras MAPK pathway via the docking molecule FRS2 
which is thought to recruit the Sos/Grb2 complex to the activated receptor (Wang et al. 
1996; Kouhara et al. 1997).  In Drosophila, a distant relative of FRS2 exists, but is not 
required for the transduction of the FGF signal (A. Michelson, personal communication).  
In contrast, the adaptor molecule Dof is required for this process.  How Dof links FGFRs 
to the Ras MAPK pathway or to any other potential signaling pathways employed by the 
FGFRs is unknown.  In this project,  a yeast two-hybrid screen was conducted with the 
aim of identifying interacting partners that Dof uses to link FGFRs to their downstream 
signaling pathways.  Amongst a large number of potential candidates that were isolated, 
three candidates provide particularly informative cues about Dofs role in vivo.  Firstly, 
one of the FGFRs, Heartless, was isolated.  Subsequent work showed that Breathless, the 
second FGFR in Drosophila, could also bind to Dof in the yeast two-hybrid system.  
Second, Dof itself was isolated, suggesting that homodimerization might play a role in 
Dofs in vivo function.  Third, Ubc9, a SUMOlating enzyme, was identified as a binding 
partner of Dof, and the mutation of a putative SUMOlation site in Dof abolished its 
interaction with the receptors in the yeast two-hybrid system.  Besides the receptor 
Heartless, a number of other molecules that have been suggested to be involved in 
signalling pathways were isolated.  Other molecules, like a CDEP homologue may 
provide a direct link to the cytoskeleton, implicating Dof in the activation of pathways 
other that the MAPK pathway.   
 
3.1 Summary of the yeast two-hybrid screen  
 
1.3 x 106 transformants from a Drosophila cDNA expression library derived from 0  18 
hour old embryos were used to screen for yeast two-hybrid interactions with the Dof 
deletion construct Dof∆C.  269 clones activated the markers lacZ and His3.  Plasmid 
DNA was isolated from these 269 positive colonies and retested for His3 activation with 
DB-Dof∆C and for autoactivation.  128 clones did not autoactivate but still activated the 
His3 reporter.  This group was called the group of His3+ positives. The 5 prime end of 
each clone was sequenced and the clones were subsequently organized into 15 groups of 
transcripts that were represented more than once, and 34 single copies.  The longest clone 
from each group and each of the single copies was subsequently tested for activation of 
the more stringent reporter, Ade2.  Eight groups and three single clones still activated the 
Ade2 reporter, and these clones were called the group of Ade2 positives. 
The strain PJ694-a was used for the yeast two-hybrid screen because it minimizes 
false positives that have an affinity for a specific promoter sequence.  Thus, in contrast to 
earlier yeast two-hybrid reporter strains, a different promoter sequence is placed 
downstream of each reporter, ensuring that if all three reporters are activated, this is not 
due to an affinity of the interactor with the promoter sequence.  Unfortunately, and for 
unknown reasons, the Ade2 reporter has been shown to be particularly stringent and 
according to some reports, does not reflect weak yeast two-hybrid interactions (Phillip 
James, personal communication).  Thus, while the differentiation between Ade2 and His3 
positive groups is one way to distinguish between true and false interactors, the His3 
positive clones were nevertheless considered to be potential binding partners of Dof. 
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Three Ade+ candidates and eleven His+ candidates isolated in the yeast two-
hybrid screen have transcripts that are out of frame with the activation domain sequence.  
This would mean that a different reading frame from the wild-type open reading frame is 
read by the translational machinery.  It has been observed, however, that during 
translation, a certain amount of slippage of the ribosome over stop codons or any other 
sequence can occur, resulting in a shift of the reading frame and the translation of a 
protein that is the same as that of the wild type sequence.  The candidate group of 
transcripts coding for the homologue of rps10 are all out of frame.  In fact, both incorrect 
frames are represented, but no in-frame clone is represented in the group.  Another 
candidate, clone i8, which corresponds to the transcript of the sinuous gene, is also out of 
frame.  Fusion proteins in both other frames were subsequently tested, but neither of 
these interacted with Dof in the yeast-two hybrid system.  However, one of the out-of-
frame His+ clones isolated in this screen, Rack1, has been shown to immunoprecipitate 
with Dof (M. Affolter, personal communication).  Taken together, if a transcript is out of 
frame with the activation domain sequence, this does not immediately mean that the 
interaction observed in the yeast two-hybrid system is false.   
 
 
3.2 Interaction of Dof with FGFRs in the yeast two-hybrid system 
 
 
Dof was found to interact with both FGFRs in the yeast two-hybrid system.  In the screen 
itself, five transcripts corresponding to cytoplasmic domain of Heartless were isolated.  
The second Drosophila FGFR, Breathless, was subsequently also shown to interact with 
Dof in the yeast two-hybrid system.  It is possible that Breathless was not isolated in the 
yeast two-hybrid screen because its transcripts are not highly represented in the 
expression library that was used or that the intron in the Breathless transcript was not 
efficiently spliced. 
 
Regions in the FGFRs that contact Dof in the yeast two-hybrid system 
 
The crystal structure of the cytoplasmic domain of human FGFR1 (Mohammadi et al. 
1996) is depicted by a ribbon diagram in Figure 3.1A.  Given the high conservation of the 
FGFRs (except for the juxtamembrane region, see below), it is likely that the cytoplasmic 
domains of Breathless and Heartless have a similar structure and the crystal structure of 
FGFR1 can therefore be used to illustrate which domains of Heartless and Breathless are 
contacting Dof in the yeast two-hybrid system.   
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A B
 
 
Figure 3.1 A and B are ribbon diagrams of the cytoplasmic FGFR1 structure, which does not include the 
juxtamembrane region and the last few residues of the C-terminus (adapted from Mohammadi et al. 1996).  
The α helices are shown in red, the β strands in green, the nucleotide-binding loop in orange, the catalytic 
loop in blue, the activation loop in yellow , the kinase insert in black, and the side chains of Tyr-653 and 
Tyr-654 in purple.  In B, the region that is colored is equivalent to that encoded by i79, the shortest 
Heartless transcript isolated in the yeast two-hybrid screen. 
 
The longest Heartless construct isolated in the screen corresponds to the complete 
cytoplasmic domain, including the juxtamembrane region, which is not shown in the 
figure because its crystal structure was not solved.  The shortest Heartless construct (i79) 
and its Breathless equivalent that bind to Dof encode the C-terminal half of the 
cytoplasmic domain, (shown in color in Figure 3.1A) which contains most of the kinase 
domain, but not the ATP binding site (shown in orange in Figure 3.1A).  This binding 
behaviour stands in contrast to FRS2, the adaptor molecule of vertebrate FGFRs, which 
binds to the juxtamembrane region of FGFR1 (Xu et al. 1998; Ong et al. 2000).  
Interestingly, the juxtamembrane region of Heartless and Breathless is not highly 
conserved with that of FGFR1.   
 
Regions in Dof that contact the FGFRs in the yeast two-hybrid system 
 
Requirement of the N-terminus of Dof for binding to the FGFRs 
 
In order to find out which part of Dof is binding to the FGFR, the cytoplasmic domain of 
Heartless was co-expressed with a panel of Dof deletion constructs and assayed for 
activation of the His3 and Ade2 reporters.  The whole C-terminal half of Dof (construct 
405) could be removed without affecting the interaction.  In contrast, when parts of the 
N-terminus were removed from Dof, interaction did not occur.  One construct behaved in 
an unpredicted way: Construct 427 contains deletion at its N- and C-terminus, but still 
interacts with the receptor.  This might reflect the fact that cis interactions amongst 
regions of the Dof molecule are regulating its binding affinity to interacting partners. 
 
Behaviour of the C-terminus of Dof 
 
The screen was conducted with a Dof construct containing a C-terminal deletion 
(Dof∆C), but a subsequent test showed that full length Dof also binds to the entire 
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cytoplasmic domain of Heartless (Figure 2.7).  However, this binding is not strong 
enough to activate the stringent reporter Ade2, indicating that the C-terminus of Dof 
might obstruct its contact with the receptor.  In fact, the minimal receptor domains of 
both Heartless and Breathless could only interact with Dof on Ade2 when the whole C-
terminal half was deleted (construct 405, Figure 2.7).  If these yeast two-hybrid 
interactions reflect the in vivo binding of Dof to the receptor, they indicate that the N- and 
C- terminus of Dof can modulate its binding affinity to the receptor. 
 
An amino acid substitution that abolishes interaction between Dof and the receptor 
 
In a separate set of experiments, the third putative SUMOlation site in Dof was mutated 
by substituting the amino acid lysine at position 297 for an Arginine.  This mutation was 
introduced into the construct Dof∆C and resulted in a complete disruption of interaction 
between the two FGFRs and Dof (Figure 2.17).  Since this amino acid substitution did 
not affect the binding of Dof to any other interaction partner it is likely that no major 
structural changes have been induced by the K297R mutation.  If indeed this amino acid 
substitution has created a molecule that cannot be SUMOlated it could mean that 
SUMOlation is required for Dofs in vivo function.  The requirement of a SUMOlation 
site for protein-protein interaction has been previously observed in the SUMO target 
RanGAP1.  RanGAP1, the GTPase-activating protein for the Ras-related GTPase Ran 
that is involved in nucleocytoplasmic transport (Mahajan et al. 1997;  Matunis et al. 
1996) is a target for SUMO1 modification.  RanGAP1 forms a stable complex with 
RanVP2/Nup358 at the nuclear pore complex.  The association of RanGAP1 with 
RanBP2 depends on the modification of RanGAP1 with a single SUMO1 molecule that is 
attached to lysine 526 in RanGAP1 (Matunis et al. 1998).  SUMO itself does not bind to 
RanBP2 and domain mapping of the binding site of RanBP2 in RanGAP1 has led to the 
speculation that SUMOlation either contributes to the RanBP2 binding or alters the 
conformation of RanGAP such that a hidden binding site becomes accessible. 
 Thus, Dof might require SUMOlation for its binding to FGFRs in a similar 
fashion in which RanGAP requires it to bind to RanBP2.  Drosophila embryos that are 
homozygous mutant for Ubc9, the SUMOlating enzyme, develop normal tracheae and 
mesoderm (see discussion of Ubc9), however, it is possible that a strong maternal 
component of Ubc9 masks the requirement of Dof to be SUMOlated.  It therefore 
remains to be determined whether SUMOlation of Dof is required for its in vivo function. 
 
 
Dof might only interact with a non-phosphorylated receptor 
 
The interaction between Dof and Heartless that led to its isolation in the yeast two-hybrid 
screen occurred when Heartless was expressed as fusion protein with the Gal4 activation 
domain.  However, when the full length cytoplasmic domain is expressed as a Gal4 
binding domain fusion, interaction with Dof no longer occurs. 
 
Although it is commonly observed that an interaction in the yeast two-hybrid system 
occurs in one direction, but not the other (see, for example, Dof dimerization 
experiments), the lack of binding of Dof to Heartless when it is fused to the binding 
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domain may possibly be attributed to the receptors ability to autophosphorylate itself.  
Xu H. et al. (1998) showed that when FGFR-1 cytoplasmic domains are brought together 
at the Gal4 binding sites, autophosphorylation occurs.  It is therefore plausible that Dof 
does not bind to DB-Heartless because it is phosphorylated.  Thus  Dof might only be 
able to bind to activation domain fusions of Heartless and Breathless because they are not 
phosphorylated.  Indeed, when the ATP binding domain of a DNA binding fusion of 
Breathless is removed, a weak activation on His3 can be observed (Figure 2.5), indicating 
that the reason why the full length cytoplasmic domain of Heartless does not interact with 
Dof in this direction might be because it is phosphorylated.      
  
While further experiments, such as co-immunoprecipitations, have to confirm that Dof 
does bind directly to the FGFRs, the yeast two-hybrid data imply that Dof does interact 
directly with the receptor, most likely with the unphosphorylated receptor.  When Dof is 
expressed in Schneider cells in the presence of a consitutively active Breathless receptor, 
it does not co-immunoprecipitate (R.Wilson, personal communication), supporting the 
idea that if Dof does bind to the FGFRs, then it only binds to the un-phosphorylated 
receptor.  This observation has implications for the function of Dof and could mean that 
Dof binds to the receptor when it is inactive and upon activation, is released from the 
receptor and can thereby activate downstream targets. 
Thus, the mechanism by which it transduces the FGF signal is different from 
docking molecules like FRS2, which bind to the phosphorylated receptor and link it to 
Sos/Grb2 and subsequently to the Ras MAPK pathway.  It is also possible that Dof 
provides structural support for the inactive receptor, in the manner of a co-receptor.  Or it 
is even possible that Dof binds to receptor because it plays a role in a process unrelated to 
the receptors signaling function, like in its transport to the plasma membrane. 
 
3.3  Dof self-association 
 
Prior to conducting the yeast two-hybrid screen for proteins that interact with Dof, co-
expression experiments of DB-Dof∆C with AD- Dof∆C had demonstrated that Dof can 
homodimerize.  In the yeast two-hybrid screen using DB-Dof∆C as bait, Dof was isolated 
as a candidate.  In order to test the in vivo relevance of this dimerization behaviour, the 
yeast two-hybrid system was employed to define the regions of the molecule that lead to 
dimerization.   
 
Regions of the Dof molecule that mediate dimerization 
 
Combinations of deletion constructs were co-expressed and assayed for interactions with 
each other.  This data was used to narrow down the interacting domains to the two 
separate parts of the molecule, that were vicariously defined as m#1 and Hd#2.  Briefly, 
and as discussed in detail in Chapter 2.4, region m#1 is required for the N-terminus to 
bind to itself, but is also required for binding to the C-terminal domain, Hd#2.  On the 
other hand, Hd#2 cannot bind to itself.  Finally, in some co-expressions, it appeared that 
the C-terminus weakens the self-association.   
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Figure 3.2  The arrows in this figure show the domains of Dof do or dont bind to each other in the yeast 
two-hybrid system 
 
Since the third potential SUMOlation site lies within the region m#1, a mutation in the 
SUMO acceptor site, namely the lysine at position 297, was introduced.  The reasoning 
behind this was that yeast SUMO dimerizes in the yeast two-hybrid system (I. 
Schwienhorst, personal communication).  It would therefore be possible, given that Ubc9 
binds to Dof, that the SUMO moiety was dimerizing, thus causing the Dof molecule to 
dimerize.  However, when the mutation is introduced into the BD-Dof∆C and AD-Dof∆C 
constructs, they still interact, indicating that the SUMOlation site does not mediate 
interaction between the two m#1 domains. 
 
The matrix of Dof deletion interactions narrows down the domains of Dof that are 
required for an interaction to occur, but it is still necessary to test whether domain m#1 
expressed on its own can bind to itself and to Hd#2.  However, if interaction does not 
occur in the yeast two-hybrid system, it would remain possible that a structural element is 
missing when m#1 is expressed on its own. 
 
Although dimerization of the Dof molecule is observed in the yeast two-hybrid system, it 
remains to be determined whether this behaviour is important for its function in vivo.  An 
interallelic complementation test that confirms its relevance has already been done by R. 
Wilson (personal communication).  The construct 430 does not rescue tracheal 
development and neither does the construct 405.  Construct 430 lacks the m#1 region, 
whereas construct 405 lacks the C-terminus.  These two constructs dimerize in the yeast 
two hybrid system, and when expressed together in the trachea, can rescue the dof mutant 
phenotype.  Further experiments will have to confirm that rescue is occuring via 
dimerization, and not via intermediate molecules, but this experiment indicates that 
homodimerization might be important for the in vivo function of Dof. 
 
 Possible conformations of the dimer 
 
In the yeast two-hybrid system, dimerization of the Dof molecule that leads to reporter 
activation must occur in trans for the activation and binding domains to be brought 
together.  Thus, in vivo, one Dof molecule might bind in trans to a second Dof molecule 
via the domains m#1 and Hd#2.  The conformation of two Dof molecules only binding in 
trans are shown in Figure 3.3 A-C.  It is also possible for any of these combinations to 
form a multimer consisting of Dof dimers.  However, it is equally likely that the molecule 
is folded on itself, resulting from the C-terminus binding to the N-terminus.  This could 
occur at the level of a single molecule (Figure 3.3 D), or several molecules could be 
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folded upon themselves and at the same time bind to a second Dof molecule (Figure 3.3 
E and F).   
 
m#1Hd#2
A
B
C
       
m#1
Hd#2
D. E. F.        
 
Figure 3.3  This figure show models of possible homodimers that can result from Dof self-association. 
 
Cis interactions 
 
As discussed above, it is possible that the C-terminal domain Hd#2 binds in cis to the N-
terminal domain m#1.  This possibility is strengthened by the fact that in yeast two-
hybrid assays, the full length Dof molecule often interacts less strongly with binding 
partners than the C-terminal deletion construct, meaning that the C-terminus might block 
an interaction domain (see Dof-FGFR interactions or Dof dimerizations).  There is no 
proof, however, that this is functionally relevant, especially since C-terminal deletions of 
the Dof molecule, when expressed in the trachea, do not give a constitutively active 
phenotype (for example, excessive branching, as seen in the case of constitutively 
activated Breathless expressed in the trachea). 
 
Dimerization as a mechanism in signal transduction 
 
Dof might assemble a multicomponent signaling complex by dimerizing.  It also could 
use self-interaction in cis or trans to regulate its activity.  Self-interaction has been 
observed in various molecules, including the scaffold protein Ste 5 in Saccharomyces 
cerevisiae.  Its dimerizing behaviour has been characterized and can serve as an example 
of how self-interaction can mediate signaling.  Dimerization has been shown to be 
essential for Ste5s function (reviewed in Garrington and Johnson, 1999), which is to act 
as a scaffold for the MAPK cascade components in a yeast pheromone response pathway.  
An N-terminal Ring-H2 domain (Inouye et al. 1997) mediates Ste5 dimerization.  This 
domain also binds to Ste4, the Gβ subunit of the heterotrimeric guanine nucleotide-
binding protein that is released from the pheromone receptor upon its activation.  By 
artificially inducing dimerization in mutant and wild type Ste5 constructs, Inouye et al. 
showed that a complementation of ste4∆ste5∆ occurs if the molecule lacking a functional 
Ring-H2 domain can dimerize artificially (by fusing the molecules to GST, which 
dimerizes).  However, complementation of ste4∆ste5∆ does not occur when the GST 
construct contains a functional Ring-H2 domain, indicating that the Ring-H2 domain 
might inhibit Ste5 from dimerizing, but upon Gβ binding, promote a conformational 
change that permits Ste5 dimerization. 
Dof does not have a Ring-H2 domain and has not been shown to bind to 
components of the MAPK pathway, but the mechanism of Ste5 scaffold function via 
dimerization provides a basis for understanding the possible mode by which Dof 
transduces a signal from the FGF receptor.  It is possible that in a similar manner to Ste5, 
Dof uses dimerization as a means to assemble a multicomponent signaling complex to 
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channel specific sets of signaling molecules into one direction.  Like the control of Ste5 
by the Gβ subunit, dimerization of Dof could be controlled by other molecules which 
induce it to self-associate upon receptor activation.  Dof is not evolutionarily conserved 
and it is interesting to note that Ste5 is not evolutionarily conserved either, giving rise to 
the idea that signaling networks of evolutionarily highly conserved molecules might be 
mixed and matched by species specific intermediate proteins to give rise to the unique 
phenotype of each species. 
 
3.4 Potential role of Dof SUMOlation 
 
The SUMOlating enzyme Ubc9 was isolated in the yeast two-hybrid screen as a binding 
partner of Dof.  It has been shown that SUMOlation can mediate the intracellular 
localization of proteins, as well as their interaction with other molecules (reviewed in 
Melchior 2000).  Experiments from this work suggest that Dof might be SUMOlated.  A 
mutation in Dofs third putative SUMOlation site abolishes its yeast two-hybrid 
interaction with the FGFRs.  The third putative SUMOlation site lies in the region that is 
deleted in construct 430.  The region deleted from this construct is particularly relevant 
for the in vivo function of Dof because this construct does not rescue the dof mutant 
phenotype.  In fact, the protein encoded by construct 430 is predominantly found in the 
nucleus (R. Wilson, personal communication) which contrasts with the cytoplasmic 
localization of wild-type Dof (Vincent et al. 1998).  Since SUMOlation has been shown 
to mediate protein localization, it is possible that this site mediates Dof localization to the 
plasma membrane or its retention in the cytoplasm.  The relevance of this mutation 
remains to be tested in vivo, namely by assaying whether the SUMO site mutant can 
rescue the dof mutant phenotype.  Furthermore, it remains to be established whether Dof 
is SUMOlated in vivo.  Ubc9 still interacts with the SUMOlation site mutant in the yeast 
two hybrid assay.  This has been observed for other Ubc9 targets, like RanBP2 (Lee et al. 
1998), which still coprecipitates with Ubc9 when it is not SUMOlated.  Tracheal and 
mesoderm development in Ubc9 mutant embryos was found to be as in wild type 
embryos.  However, this does not mean that Ubc9 SUMOlation is not required, since the 
possibility remains that the mutant embryo inherits a maternal supply of Ubc9.   
 
So far, the majority of SUMO targets that have been described function in the nucleus 
and have to be SUMOlated to get there.  If Dof does indeed require SUMOlation for its 
function, it could mean two things, namely that it might have an unknown function in the 
nucleus or that SUMOlation might regulate its cytoplasmic localization, retention or 
interaction with other molecules. 
 
3.5 Conclusion 
 
In the yeast two-hybrid screen for interacting partners of Dof, a number of candidates that 
give clues to how Dof is functioning in vivo were identified.  Many of these candidates, 
especially those that have been implicated in signaling functions or those which might 
play a role in signaling to the cytoskeleton, remain to be characterized.  The three 
candidates studied in more detail in this project raise some interesting possibilities for 
Dofs function in FGF signal transduction.  Dofs binding behaviour with the FGFRs in 
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the yeast-two hybrid system indicates that it might bind to the non-phosphorylated 
receptor and that regions within the molecule affect the affinity with which it interacts.  
The binding of Dof to the FGFRs might be regulated in vivo by its post-translational 
modification with a SUMO moiety at its N-terminus, since the putative SUMOlation site 
in Dof is required for its interaction with the FGFRs in the yeast two-hybrid system.  
Finally, since Dof self-associates in the yeast two-hybrid system, it is possible that 
dimerization is important for its function.   
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4. MATERIALS AND METHODS 
 
 
4.1 Materials 
 
Saccharomyces cerevisiae (S.cerevisiae) 
 
The yeast strain PJ69-4Α (gift from Phillip James) was used for all yeast two-hybrid 
assays.  The genotype of PJ69-4A is MATa trp1-90 leu2-3,112 ura3-52 his3-200 gal4 
gal80LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ.  
 
Escherichia coli (E. coli) 
 
JM107  (endA1, gyrA96, thi, hsdR17, supE44, relA1, (lac-proAB),(F, traD36, 
proAB+, lacIq lacZM15) (Yannisch-Perron et al. 1985) 
 
DH5α  (supE44 ∆(lac ZYA-argF)U169 (Φ80 lacZDM15) hsdR17(rk-mk+) recA1 endA1 
gyrA96(NaIr) thi1 relA1) 
 
Drosophila melanogaster 
 
Wild type flies were w1118.  Unless mentioned otherwise, strains were obtained from 
Bloomington, Indiana.  A description of balancers and markers can be found in Lindsley 
and Zimm (1992). 
 
DNA constructs 
 
Constructs used in this work are described in Appendix IV. 
 
Antibodies 
 
The following primary antibodies were used: monoclonal mouse mAB2A12 ( provided 
by N. Patel) was used at 1: 10, mouse anti-FasciclinIII (provided by R. Smith) was used 
at 1:10, and rabbit anti-Eve (provided by M. Frasch) was used at 1:2000 .  
 
Oligonucleotides 
 
Oligonucleotides were purchased from Eurogentech. The lyophilized pellet was 
resuspended in water to a concentration of 100pmol/µl and stored at 20°C. 
 
 
Computer Software and digital Photography 
 
Digital pictures were taken of images under Axiophot Photomikroscop (Zeiss) with the 
ProgRes 3008 (Kontron Elektronik) camera.  Pictures were edited using Adobe 
Photoshop (Adobe systems) software.  Figures were drawn using Canvas 7.0 (Deneba 
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Systems) software.   DNA sequence alignments and analysis were made using VectorNTI 
(InforMax Inc.) software.  
 
Chemicals and Reagents 
 
Tris was purchased from Applichem, Aquaphenol purchase from Appligene.  Roche 
Diagnostics GmbH supplied herring sperm DNA (used for hybridization buffer), 
Nitroblue tetrazolium (NBT), 5-bromo-4-cholor-indoxylphophate (BCIP), unlabeled 
nucleotides, Hexanucleotide Mix, DIG-DNA labelling mix, anti-DIG antibody, 
Proteinase K and Expand Enzyme Mix.  Agarose Electrophoresis Grade, Casein 
Hydrolysate, Yeast Extract, and Select Agar were purchased from Gibco BRL. 
Acelylated Bovine Serum Albumin (BSA) was purchase from New England Biolabs. 
Heparin was bought from Serva and Sigma supplied Tween20, tRNA, RNase. 
Ampicillin, and Tetracycline. Amino Acids were purchase from Sigma. Molecular 
Weight Markers.  The λ/HindIII Marker and the 1kb ladder were purchased from NEB.  
Restriction enzymes and their reaction buffers were supplied by New England Biolabs 
and Roche Diagnostics GmbH.  Unless otherwise mentioned, all other chemicals were 
purchased from Merck (Darmstadt), Sigma (Deisenhofen) or Roth (Karlsruhe). 
 
4.2 Methods 
 
Sequence similarity and motif searches 
Sequence similarity searches were conducted using the Basic Local Alignment Search 
Tool (BLAST) developed at NCBI (National Center for Biotechnology Information, 
http://www.ncbi.nlm.nih.gov/).  Searches for annotated Drosophila genomic sequences, 
Drosophila ESTs and Drosophila deficiency and P-element insertion strains were 
conducted using FlyBase (FlyBase (1999);http://flybase.bio.indiana.edu/) Motif searches 
were conducted using PFAM at the website 
http://www.sanger.ac.uk/Software/Pfam/search.shtml (Bateman et al. 1999). 
Embryo collections and maintenance of flies 
 
The flies (Drosophila melanogaster) were maintained under standard conditions 
(Ashburner, 1989; Wieschaus and Nüsslein-Volhard, 1986) and the embryos were 
collected under standard conditions (Ashburner, 1989; Wieschaus and Nuesslein 
Volhard, 1986).  
 
Molecular biology 
 
The methods used for cloning were those descirbed in Sambrook et al. (1989) 
 
DNA sequencing 
 
DNA was sequenced by the primer extension dideoxynucleotide extension method 
(Sanger, 1977) using a Dye-Terminator Kit (Perkin-Elmer) and the sequencing reaction 
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was read by a 373A ABI-Sequencer (Applied Biosystems).  DNA for the sequencing 
reaction was prepared either by the alkaline miniprep procedure or by using the Jetstar 
Plasmid Midiprep Kit.  DNA sequences were aligned using the computer software Vector 
NTI (InforMax Inc.). 
 
Competent E. Coli cells 
 
Electrocompetent cells were prepared using the method developed by Hanahan et al. 
(1995).  Chemical competent cells were purchased from GibcoBRL. 
 
In situ hybridization to embryos with DIG-labeled RNA probes 
 
In situ hybridizations were conducted as described by Tautz and Pfeifle (1989) Since 
DIG-labeled RNA probes were used, hybridization was carried out at 55°C. 
 
Digoxigenin (DIG) labeling of RNA 
 
DIG labeled RNA probes were prepared by using a PCR product as a template for the 
transcription reaction.  The DNA template was made using primers containing the core 
sequence of  T7, T3 or SP6 RNA polymerase binding sites.  For antisense probes of 
inserts in the vector pACT2, the primers #130 and #131 were used.  For sense probes of 
inserts in the vector pACT2 (used as a control), the primers #132 and #133 were used.  
For antisense probes of inserts in the vector pOT2, primers #165 and #170 or #166 and 
#170 were used.  
 
primer#  name vector primer sequence (5 to 3 direction) Polymerase binding site 
#130 act25 pACT2 tggtcatatggccatggagg none 
#131 T7αsense pACT2 taatacgactcactatagggaggacgattcatagatctctc T7 polymerase 
#132 act23 pACT2 tgcacgatgcacagttgaag none 
#133 T7sense pACT2 taatacgactcactatagggaggtcatatggccatggaggc T7 polymerase 
#165 pOT2 p3 pOT2 catacgatttaggtgacactatagcgttagaacgcggctac SP6 polymerase 
#166 pOT2 p4 pOT2 attaaccctcactaaagggacgttagaacgcggctacaat T3 polymerase 
#170 T7 pOT2 taatacgactcactatagggaga none 
 
Table 4.1:  This table lists the primer used to generate PCR products used as templates for making DIG-
labeled probes. 
 
The PCR reaction was assembled in a total volume of 25µl using the following 
components: 20ng plasmid DNA, 25pmol each primer, 1µl 10mM dNTP, Expand PCR 
Buffer (2.5mM MgCl2) and 1µl Expand Taq polymerase (3.5 units) added last.  The PCR 
conditions were 2 minutes at 94°C and then 30 cycles of 94°C (10 seconds), 68°C (30 
seconds) and 72°C (2 minutes).  The concentration of PCR product was estimated on an 
agarose gel using the λ/HindIII marker as a reference.  For the DIG labeling reaction in a 
final volume of 20µl, 100-200ng PCR product was added to 2µl DIG RNA Labeling Mix 
10X (10mM ATP, 10mM CTP, 10mM GTP, 6,5mM UTP, 3.5mM DIG-11-UTP, Roche 
Diagnostics GmbH), 2µl 10X Transcription Buffer (400mM Tris-HCl, pH 8.0 (20°C), 
60mM MgCL2, 100mM DTT, 20mM Spermidine; Roche Diagnostics GmbH) 0.5µl 
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RNase Inhibitor ( 40U/µl, Promega ), 2µl 100mMDTT and deionized water to a final 
volume of 20µl.  After all reaction components had been assembled, 2µl RNA 
polymerase (40 Units) were added and the reaction was incubated at 37°C for 2 hours.  
Afterwards, the reaction mix was brought to 100µl with hybridization mix (1:5 dilution) 
and stored at 20.  The probe was used for in situ hybridizations at dilutions ranging from 
1:20 to 1:20 000, depending on the probe. 
 
Immunohistochemistry on Drosophila embryos 
For antibody stainings, the method described by Mitchison and Sedat (1983) was used.  
PBS (100mM Na-Phosphate pH7.1, 130mM NaCl) was used instead of Buffer AM and 
10%BSA was used instead of 10%NGS.  The biotinylated secondary antibodies were 
visualized with Vectastain-ABC-Kit (purchased from Camon-Labor-Service), using the 
manufacturers specifications 
 
Embedding embryos in Araldite 
 
For microscopy, embryos were embedded in Araldite.  Embryos in PBS (100mM Na-
Phosphate pH7.1, 130mM NaCl) were rehydrated by short 30%, 50%,90% and 96% 
EtOH washes.  This is followed by a 10 minute incubation in 100% water-free EtOH 
(EtOH stored with Molecular Sieves, Sigma M-2010, 1/8 inch pellets) and then by a 
gravity wash in water-free Acetone.  About 100µl Araldite:Acetone 1:1 mix (reagents for 
Araldite supplied by Sigma) was then added to the embryos and these were then 
transfered into a shallow plastic lid containing pure Araldite.  
 
Isolation of DNA from adult flies 
 
20 flies were homogenized in 250µl Buffer A ( 0.1M Tris pH9, 0.1M EDTA, 1%SDS).  
Another 250µl Buffer A was subsequently added and the solution was incubated at 70°C 
for 30 minutes followed by 5 minutes at 0°C.  Then 70µl 8M KoAc was added and the 
solution vortexed.  After vortexing, the solution was incubated for 30 minutes at 0°C and 
then centrifuged in a 12000 bench top centrifuge for 10 minutes.  The supernatant was 
transfered to a fresh 1.5ml Eppendorf tube and the genomic DNA was precipitated with 
0.7 volumes Isopropanol.  The pellet was resuspended in 200ml TE and the suspension 
was extracted twice with Phenol/Chloroform/Isoamylalcohol 25:24:1.  The genomic 
DNA was then precipitated with 2.5 volumes Ethanol and 1/10 volume 3MNaOAc pH 
5.2.  The pellet was washed with 70%EtOH and brought to an approximate concentration 
to 500ng/µl. 
 
PCR  
 
The PCR was carried out in a UNO Thermoblock (Biometra).  The reaction components 
were: 20pmol each primer, 20ng template DNA (for analytical purposes) or 1µg template 
DNA if the template was used for cloning, 1xPCR buffer (supplier), 10pmol dNTPs and 
0.75µl Expand enzyme mix (Expand High Fidelity PCR System, Roche) in 50µl reaction 
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volume.  The reaction conditions were optimized for each primer pair, but essentially, 
underwent 30 cycles of 1 minute at 95°C, 1 minute at the annealing temperature 
optimized for the specific primer pair, and 1 minute (or more, depending on size of PCR 
product) extension at 72°C. 
 
 
4.3 Methods for yeast two-hybrid assays 
 
Media Recipes  
 
Most Recipes and Protocols used for experiments with Saccharomyces cerevisiae were 
adapted from protocols provided by the  Gietz home page 
http://www.umanitoba.ca/faculties/medicine/units/biochem/gietz/.   
 
Liquid YPAD (Yeast Extract-Peptone-Dextrose plus Adenine medium): 6g yeast extract, 
12g Peptone, 12g Glucose, 60mg adenine hemisulphate, 600ml distilled water.  Sterilise 
by autoclaving 20 minutes at 15 lb/sq.in. on liquid cycle.  For solid medium: prepare 
liquid YPAD and add 10g Bacto-agar (Difco) before autoclaving.  
SC drop-out Medium (Synthetic complete Drop Out Medium): 4.0g Difco Yeast Nitrogen 
Base (without amino acids), 12g Glucose, 0.4g Synthetic Complete Drop Out Medium 
Mix (see below), 600 ml distilled water.  Mix all ingredients in water and adjust the pH to 
5.6 with 10N NaOH.  Sterilise by autoclaving 20 minutes at 15 lb/sq.in.  on liquid cycle.  
For solid medium, add 10g Difco Bacto Agar before autoclaving. 
Synthetic Complete drop-out Medium Mix:  2.0g Adenine Hemisulfate, 2.0g Arginine 
HCl, 2.0g Histidine HCl, 2.0g Isoleucine, 2.0g Lysine HCl, 2.0g Methionine, 2.0g 
Tyrosine, 2.0g Threonine, 2.0g Serine, 4.0g Leucine, 3.0 g Phenlyalanine, 3.0 g 
Tryptophane, 1.2g Uracil, 9.0g Valine.  Store mix at room temperature.  Note: this mix is 
made by omitting the component for which is to be selected.  Thus, SC  Leu means 
that Leucine has been omitted 
 
Frozen Cell transformation method  
 
For standard transformations of S. cerevisiae, a variation of the frozen yeast method was 
used (Dohmen et. al 1991).  To the frozen cell suspension (see below) 0.1-5 µg plasmid 
DNA and 50µg herring sperm DNA (5µl of 10mg/ml Stock, provided by Clontech) in a 
maximum volume of 20µl were added.  This suspension was mixed for 2 minutes or until 
cells were thawed.  1ml Solution 2 ( 40% PEG1000 (Roth#0150.1), 0.2M Bicine-NaoH  
pH 8.35 (Sigma B8660);sterilized by autoclaving 20 minutes at 15 lb/sq.in. on liquid 
cycle) was added and mixed by inverting the tube 2-3 times.  This suspension was 
incubated at 30°C for 1hour.  The cells were then collected by spinning them down at 
3000g for 5 seconds and resuspending the pellet in 200µl Solution 3 ( 0.15M NaCl, 
10mM Bicine-NaOH pH8.35 (Sigma B8660);sterilized by autoclaving 20 minutes at 15 
lb/sq.in. on liquid cycle) and plating the suspension onto SC omission medium.  
Transformants could be seen after an incubation at 30°C for 2 days. 
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Preparation of cells for the  frozen yeast method 
 
Cells (10ml per desired transformation) were grown overnight at 30°C in YPAD to an 
OD600 of 0.6-0.8 (which amounts to about 0.6-1 x 10
7 cells/ml).  Cells were washed in 0.5 
volumes Solution 1 (1.0M Sorbitol, 10mM Bicine-NaOH (pH 8.35) Sigma B8660, 3% 
Ethylene glycol, 5% DMSO (Sigma D8418); sterilized by autoclaving 20 minutes at 15 
lb/sq.in. on liquid cycle) and resuspend in 0.02 volume Solution 1.  200µl aliquots were 
frozen slowly by placing cells at 70°C within a styropore box. 
 
Description of pACT2 Drosophila embryonic expression library  
 
The cDNA library in pACT2 (Durfee et al. 1993) used for the yeast two hybrid screen 
was a gift from S. Elledge.  The cDNA for the library was made from mRNA from 0-18 
hour old embryos and was size selected to be larger than 1kb.  The library was received 
in the lamda phage λACTand was reported to have between 1x107 and 1x108 total 
recombinants, amplified only once from the packaging (S.Elledge, personal 
communication) The titer was 2x109 PFU/ml (the bacterial strain used for this 
measurement was DH5α).  The strain JM107/λKC was used to convert the phage vector 
into plasmid vector (see below). Information about the priming method for the 
constuction of the library was not given.  The  sequence of the clones isolated in the 
screen have the following 5 prime and 3 prime vector ends: 
ggggatccgaattcggcacgagxxxxx........xxxxxttttctcgag where x represents the sequence   
from the cDNA insert. 
 
Automatic subcloning conversion of λACT into pACT 
 
The Drosophila cDNA library in λACT (see above) was converted from a phage library 
into the pACT plasmid library by infecting the bacterial strain JM107/λKC, a kanr lamda 
lyosgen containing the cre gen, with the λACT phage library. Upon infection of 
JM107/λKC with the library, the plasmid is excised via cre-mediated lox recombination, 
thus creating Ampr colonies. The detailed protocol (adapted from Durfee et al.) is 
described below. 
A single JM107/λKC colony was used to inoculate 50ml LB-kan (10µg/ml) 0.2% 
Maltose.  The culture was grown overnight at 37°C on a shaker at 200 cycles/minute.  
The next day, the pellet of cells from 2ml of overnight culture were resuspended in 2ml 
0.01M MgCl2 and subsequently infected with 300µl λACT phage solution (equivalent to 
about 5x108 PFU according to titer determined with DH5α, see above) and left to 
incubate for 30 minutes at 30°C without shaking.  2ml LB was then added and the culture 
was shaken for 1hr at 30°C.  The total volume of 4.05ml was plated onto 10 X 150mm 
LB-amp 50µg/µl plates and grown at 37°C overnight.  The total number of transformants 
was 1.873 x 1010.  This indicates that the titer determined using DH5α cells was an 
underestimation.  The next day, plasmid DNA was prepared directly from the lysogens 
scraped from the 10 plates by growing them at 37°C to an OD of 1.1-1.2 in 6L terrific 
broth (4x1.5L) and then spinning them 20 minutes 8000rpm (Sorvall superspeed 
centrifuge - Du Pont).  The pellet was vortexed and resuspended in 60ml Solution I 
(4x15ml).  After vortexing, Solution II was added.  The solutions were mixed by 
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vortexing and then Solution III was added.  The solution was transfered to 50ml Falcon 
tubes and then spun in an Hereaus 20 minutes 4000rpm.  The plasmid DNA was 
precipitated out of the supernatant at room temperature with 0.7 volume Isopropanol and 
recovered by spinning for 20 minutes at 4000rpm (Hereaus).  The pellet was resuspended 
in 2ml H2O and 2ml 5MLiCl.  This was spun once again 20 minutes 4000rpm in an 
Hereaus.  The pellet was resuspended in 10ml H2O and  2.5-3volumes EtOH were added.  
The solution was spun for 20 minutes at 4000rpm and the pellet was resuspended in 3ml 
H2O.  180µlEtBr (10µg/µl) was then, followed by 2.1ml 7.5M NH3OAc, and then mixed.  
Then 4.8ml Phenol/Chloroform pH 8.0. was added, the solution vortexed and then 
centrifuged for 5 minutes.  DNA was precipitated from the aqueous phase using 2.5 
volumes EtOH and washing with 70% EtOH.  The pellet was resuspended in 1.6ml 
water.  The total yield of DNA was 16.8mg from 18x109 transformants, which was half 
as much as the 2mg DNA yield from 1x109 transformants reported by Steve Elledge 
(personal communication).  10 clones were picked off dilution plate (the plate used for 
calculating total transformants) and DNA was isolated from these clones and digested 
with HindIII digest.  3/10 clones were empty.  1/10 was not pACT2.   
 
Transformation of  cDNA expression library into AR2.9 and select of  his+lacZ+ 
clones 
 
The method used for transforming the pACT2 expression library into AR2.9 was adopted 
from Gietz and Schiestl (1995) and is summarized on the world wide web at 
http://www.umanitoba.ca/faculties/medicine/units/biochem/gietz/  
 
The transformation of the library was conducted by scaling up the reaction components 
by 180X.  115.2ml overnight YPAD AR2.9 culture (4.44 x 109 cells) were pelleted and 
resuspended in 900ml YPAD.  The suspension was grown for 7 hours at 30°C to an 
O.D.600 of 1.45.  The suspension was then centrifuged and the pellet washed with an 
equal volume of millipore water.  This suspension was centrifuged (3200rpm 5 minutes 
in Heraeus Sepatech centrifuge) and the millipore water was removed from the resulting 
pellet.  This was followed by brief spin to get rid of residual water.  The following 
transformation components (equal to a 180X scale-up) were added to the pellet: 43.2ml 
PEG50% (w/v), 6.48ml 1M LiAC, 900µl herring sperm DNA 10mg/ml (Clontech), 
180µg pACT library DNA (in 600µl) and 12ml Millipore water.  The suspension was 
incubated at 30°C for 30 minutes followed by 42°C for 35 minutes (shaking every 5 
minutes).  The pellet was isolated by centrifugation and resuspended in 67.5ml SC-ULH 
liquid medium and plated onto 70  SC-ULH  selection plates (145mm).  The total number 
of transformants (measured by plating a dilution series on SC-UL selection plates) was 
1272150.  The transformation efficiency was about 7 x 103 transformants per µg library 
DNA.  The transformants were grown on SC-ULH plates for 7 days at 30°C and then 
replica plated onto SC-ULH plates containing 40µg/ml X-Gal.  After incubation at 30°C 
for two days, 269 colonies had turned blue (that is, theywere expressing the lacZ reporter 
gene) and were streak purified onto SC-ULH plates.  Plasmid DNA was isolated from the 
269 yeast colonies, transformed into electrocompetent DH5α E. Coli cells and plated 
onto standard LB-Amp plates to isolate the insert in pACT (which confers Ampicillin 
resistance to the cells).  DNA was prepared and digested with RI-XhoI to determine the 
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size of the plasmid.  The plasmid was transformed back into the strain AR2.9 (to confirm 
the interaction with Dof∆C) and in parallel into PJ69-4A/pGBDU (to test for 
autoactivation) and assayed for His3 activation on SC-ULH plates.  All autoactivators 
were discarded.  Sequence data of the 5prime end of all clones that grew on His3 was 
obtained using the primer with the sequence 5ACCACTACAATGGATGATG 3. 
 
The strain AR2.9 used for the yeast two-hybrid screen 
 
The construct int.DB-DofC was linearized with PvuI and transformed into PJ69-4Α 
and transformants were selected for growth on SC-U plates.  10 clones were streak 
purified on SC-U.  The expression of Dof∆C from the integrated construct was tested by 
assaying for His3 activation upon co-expression with AD-Dof∆C.  Several of the 10 
integration strains activated His3 upon co-expression with AD-Dof∆C.  The strain with 
which the best transformation efficiency could be achieved was selected and called 
AR2.9. 
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Appendix I.  
Different interaction strengths with different yeast two-hybrid vectors 
 
Identical proteins expressed from different vectors will exhibit different binding 
behaviour (Legrain et al, 1994). An example from this work is when the insert from the 
clone i21 (in the pACT vector) was cloned into the pGAD vector and tested for activation 
of His3 when co-expressed with DB-Dof∆C (the same construct used to isolate i21 from 
the yeast two-hybrid screen). Activation of His3 was strongly reduced, in contrast to the 
interaction observed in the yeast two-hybrid screen (Figure AI.I) 
 
 
growth after 5 days at 30°C
DB-Dof∆C
pGAD
i21
DB265
DNA
Binding
Domain
Activation
Domain
i21
SC-H SC-UL or -WL
0.001 0.01 0.1 0.001 0.01 0.1
AD-Dof∆C
DB-Dof∆C
DBi21
DB-Dof∆C i21
ADi21DB-Dof∆C
DBi21 AD-Dof∆C
 
 
Figure AI.I  This figure shows the growth of the construct i21 (in the pACT vector) when co-expressed  
with Dof∆C or full length Dof (construct 256).  When the identical sequence is cloned into the 
pGAD/pGBDU vectors (now called clone ADi21 or DBi21) and co-expressed with Dof∆C, the growth rate 
is diminished.  See Figure 2.3 for a description of the dot assay. 
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Appendix II.  
Interaction of candidates with full length Dof and construct 430 
 
All candidates from the yeast two-hybrid screed were tested for activation of the His3 
reporter when co-expressed with the full length Dof construct and the deletion construct 
430. The results are shown Table A.II. 
 
 
longest 
 clone  
int. 
Dof∆C* 
DB 
256** 
DB 
430** 
i119 +++ ++ * 
i59 ++ + + 
i14 +++ ++++ + 
i28 ++++ ++ ++ 
i238 + ++ + 
i56 
slight auto ++++ ++++ 
+ 
i133 ++ ++++ ++++ 
i150 ++++ ++++ 0 
i220 + + 0 
i6 ++++ 0 + 
i19 ++++ ++++ ++++ 
i159 ++++ ++++ ++++ 
i199 ++ + ++ 
i7 +++ ++++ ++++ 
i163 ++++ ++ ++ 
i173 +++ 0 0 
i51 + 0 ++++ 
i239 + 0 + 
i31 + ++++ ++ 
i115 +++ 0 ++ 
i207 + 0 0 
i234 
slight auto +++ ++ ++ 
i249 ++ ++ + 
i36 +++ ++++ + 
longest 
 clone  
int. 
Dof∆C* 
DB 
256** 
DB 
430** 
i94 ++ ++ 0 
i70 ++ 0 ++++ 
i188 +++ 0 + 
i184 ++ 0 + 
i50 ++ ++++ ++ 
i164 ++   
i17 ++ + 0 
i155 ++ ++ + 
i226 +++ ++ ++ 
i190 ++ ++++ ++ 
i12 +++ ++++ ++++ 
i25 
slight auto +++ ++++ ++++ 
i130 ++ ++ + 
i30 +++ ++++ ++ 
i118 ++ ++ ++ 
i8 +++ ++++ ++++ 
i136 ++++ ++++ ++++ 
i169 ++ ++ + 
i175 + + + 
i176 + + + 
i182 +++ + + 
i187 +++ 0 + 
i232 + 0 0 
 
Table AII  
* = analysis of growth on SC-ULH selection plates relative to the interaction of AR2.9 (=integrated 
Dof∆C) + ADDof∆C. ++++= faster growth than AR2.9 + AD256, +++ = same growth as AR2.9 + 
AD256,++= slower growth than int.JH17 + AD256,+ = much slower growth than AR2.9 + AD256, += 
borderline slow growth**=analysis of growth on dot assay after about 60hrs at 30°C. ++++ = normal 
growth (faster than DBDof∆C + ADDof∆C),++= ½, += ¼, += 1/8, += 1/16, *= 1/32 
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Appendix III  
Analysis of the His3 positive group i119 
 
The group i119 consists of 21 members.  Sequence analysis of the 5 prime end revealed that the transcript 
derives from the predicted gene CG12340.  All 21 members code for in-frame fusions with the Gal4 
activation domain. The gene encoding the transcript i119 is expressed ubiquitously at early stages but 
becomes restricted to the nervous system at around stage 12.  
 
i119
i10
Fibronectin type III domain
LD26050 ORF
SH3 domain binding motif
coiled coil (SMART;MacStripe)
1421aa
aa701
aa1129
 
 
Figure AIII.1  This figure shows the full length protein encoded by the expressed sequence tag cDNA LD26050 aligned with the 
shortest and longest member of group i119.   
 
The protein sequence of CG12340 does not show significant homology to any known protein.  The only 
obvious motif found in this protein sequence is a Fibronectin type III domain at its C-terminus (PFAM), a 
coiled coil domain in the middle region of the protein, and a nearby SH3 domain binding motif.  The 
expressed sequence tag LD26050 was identified as a cDNA that is identical to the predicted gene 
CG12340.   
  
Analysis of Embryos that are mutant for the gene encoding i119 
CG12340 is cytologically located at 47C1.  The deficiencies Df(2R)stan2,b1pr1P{ry+t7.2=neoFRT}42D 
(BL596) and Df(2R)E3363 (BL520) remove the genomic region around 47C1.  Tracheal development and 
mesoderm migration of embryos homozygous for these deficient regions were examined and both 
deficiencies caused a defect in tracheal development, but heart cell precursors stained with anti-
Evenskipped were normal. 
 
Analysis of genes in 47C1 
Since the deletion of the genomic region around 47C resulted in defective tracheal development, genes 
mapping to this region (including the predicted gene CG12340 identified in the yeast two-hybrid screen) 
were investigated in more detail, since the lack of any one (or more) of them could result in the defect in 
tracheal development. The genomic region removed by both deficiencies contains not only the gene 
predicted by CG12340, but several other predicted genes, including some for which mutations already 
exist.  These are brokenheart (Fremion et al. 1999), lola (Giniger et al. 1994), pipsqueak , stan, and diego 
(Susan Eaton, personal communication).  lola (longitudinals lacking) is a transcription factor required for 
the proper development of the central nervous system but not required for the development of the trachea 
(Giniger et al 1994).  Brokenheart encodes the alpha subunit of the Go protein,  and is required for the 
formation of the heart, the visceral musculature and the nervous system in Drosophila (Fremion et al 1999).  
Flies carrying a mutation in Brokenheart were not examined in this work, and it remains to be established 
whether Brokenheart, or its upstream effector Go has a role in tracheal development.  Pipsqueak is a 
transcription factor that belongs to the posterior group genes.  Embryos mutant for pipsqueak were not 
analysed here but it is unlikely that a posterior group gene would exclusively affect tracheal development.  
The gene diego is a novel gene that encodes for a protein that interacts genetically with stan (starry night), 
but does not lead to lethality when mutated, indicating that its deletion can not be the sole cause of the 
tracheal phenotype observed in the deficiency strains BL596 and BL520.  Finally, stan, a non-homotypic 
cadherin-like 7-transmembrane protein (involved in cell polarity and axon guidance) is also removed by the 
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two deficiencies.  Two null alleles of stan, fmiE59 and fmiE45 (gift from T. Uemura),  were analyzed, and 
both showed a normal tracheal development, indicating that the deletion of stan was not causing this 
phenotype.  The last option explored here was to mutate CG12340 to see whether a deletion of this gene is 
causing the tracheal phenotype observed in the two deficiencies.  The mutation of CG12340 was 
accomplished by P-element mediated excision, the excision was called ex1.7and the analysis of this 
excision is described below.  The deletion results in lethality, but tracheal development is normal.  Embryos 
die as pharate adults, some struggling to emerge from their pupal cases.  This means that the tracheal 
phenotype cannot be attributed to the lack of CG12340. 
 
P-element mediated mutagenesis of the predicted gene CG12340 
 
The fly strain EP(2)2024 contains a  P-element inserted 76 bases upstream of the first base of genomic 
sequence corresponding to 5UTR of LD26050. This insertion does not lead to lethality, meaning that the 
function of CG12340, the annotated gene coding for LD26050 might not be disrupted by the insertion, or 
that the disruption of CG12340 is not lethal.  In order to determine whether a deletion of CG12340 was the 
cause of the tracheal phenotype, a deletion of this gene was made using P-element mediated mutagenesis.  
This was done by mobilizing the P-element in the strain EP(2)2024 and isolating those flies in which the P-
element excises imprecisely.  All flies in which the P-element had excised could be indentified by their 
white-eyed phenotype.  To determine whether any of these excisions were imprecise and thereby led to 
lethality, all white-eyed flies were tested for homozygous lethality as well as for non-complemention of the 
deficiency BL596.  Three lethal excisions were isolated and called ex1.7, ex6.1 and ex2.1. They formed 
two lethal complementation groups.  The orientation of these excisions was determined by 
complementation analysis and PCR. This is described in the next section. 
 
Complementation Analysis of imprecise excisions of EP(2)2024 
 
Imprecise lethal excisions of the neighboring P-element EP(2)2619 (Suzanne Eaton) helped  to determine 
the orientation of the imprecise EP(2)2024 excisions.  In addition, the lethal mutations in starry night 
(fmiE59 and fmiE45) were used to determine the extent of the 3 excisions.  Ex2.1 and ex6.1 excise to the 5 
end because they do not complement ex7 and ex 8, but do complement ex10 and ex29.  Ex1.7 excises to the 
3end because it complements ex7 and ex8, but does not complement ex10 and ex29. 
None of the 3 excisions complement ex212, indicating that the 212 excision removed genomic DNA 
between EP(2)2619 and EP(2)2024 and that this leads to lethality.  The results from the individual 
complementation crosses are summarized in table AIII.1. 
 
 BL 
596 
BL 
520 
1.7 2.1 6.1 ex 
10 
ex 
212 
ex 
29 
ex 
7 
ex 
8 
fmiE59 fmiE45 inter 
se 
BL596 L          L L L 
BL520  L         L L L 
1.7 L L L V V L V L V V V V L 
2.1 L L V L L L V    V V L 
6.1 L L V L L L V    V V L 
ex212           (V*) (V*)  
ex10   L        (L*) (L*) L 
ex29        L V V (L*) (L*) L 
ex7        V L L (V*) (V*) L 
ex8        V L L (V*) (V*) L 
 
Table AIII.I  Complementation crosses used to determine the direction of the imprecise excisions. ex7 and ex 8 are unidirectional 
excisions of EP(2)2024 that leave the 3arm intact.ex10, ex29 and e212 are unidirectional excisions of EP(2)2024 that leave the 5arm 
intact (V): S. Eaton, personal communication but unknown which allele of fmi was used for complementation analysis 
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Figure AIII.2  The lethal complementation groups were called L1,L2, R1 and R2 and the direction of excisions is shown in the upper 
figure.  The members of each group are as follows: L2 contains ex7 and ex8.  L1 contains ex2.1 and ex6.1.  R1 contains ex1.7 and 
ex10 and R2 contains ex212.  Table AIII.2 contains the sequence of primers used for the analysis. 
 
Analysis of excisions using complementation tests and PCR 
  
ex2.1 and ex6.1 contain 5prime excisions  
 
When a P-element excises imprecisely, it is possible that one of the ends is left behind.  Therefore, genomic 
DNA from all three excisions was tested for the presence of one of the P-element ends, which would 
provide a template for one primer of a PCR product.  The gel in Figure AIII.3 shows that the starting strain 
EP(2)2024 has both inverted repeats that provide a binding site for the P-element primer, giving a product 
for both sides (lane 3 for both primer pairs).  Ex2.1 has an intact 3 prime inverted repeat and genomic 
region because primers p167 and p138 give the same product as the 3prime arm of EP(2)2024 (lane 5 for 
primer pair p167 and p138).  While the absence of a PCR product does not prove beyond doubt that the 
genomic region is missing, the data is suggestive that all other excisions lost both ends of the p-element.   
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pri.# template sequence (5-3) 
101 CG12339 aaatccttcggatatacacc
102 CG12339 ccactccgtacaaactgc
103 Mat1 gcaagaccaccaaatacc
104 Mat1 tgaactttctccagctcc
105 Rab3 atacaaaactggcccgtttcc
106 Rab3 ctgtttatgatggtgctgctgc
137 LD26050 ttgctgcagtgcctcctggc
138 LD26050 gagaccatgatgtcgcgca
139 LD26050 ctgatacgcatcgagaagac
140 LD26050 gtcttctcgatgcgtatcag
141 LD26050 actactcaaggatgatgaac
142 LD26050 taaccatcatcgcctcgacg
143 LD26050 tgcgcgacatcatggtctc
144 LD26050 cgtcgaggcgatgatggtta
145 LD26050 ggaaacaggcagctagagcg
146 LD26050 ttgttggtcgcgagcggcag
147 LD26050 ctgctcttcggaaccagttg
 
Table AIII.2  This table lists the primers used for the analysis of the genomic region around CG12340. 
 
ex1.7 contains a 3 prime excision 
 
Complementation analysis suggested that ex1.7 contained an intact 5 prime genomic region (if the 
imprecise excision has deleted part of the 5prime region, it in any case does not lead to lethality) and that 
the 3 prime deletion did not extend as far as the gene starry night.  PCR with inverted repeats suggested 
that neither inverted repeat was left behind by the excision (Figure AIII.3).  In order to determine the extent 
of the 3 prime excision, primer pairs from the three closest genes on the 3prime side of EP(2)2024 were 
used to identify the presence or absence of a genomic sequence.   
 
0.5kb
1.0kb
1.5kb
2.0kb
3.0kb
p167 + p137 p167 + p138
1 2 3 4 5 6 2 3 4 5 6 1
4. ex1.2/CyO genomic DNA
3. EP(2)2024/CyO genomic DNA
5. ex2.1/CyO genomic DNA
6. ex6.1/CyO genomic DNA
1. 1kb ladder (Gibco BRL)
2. w[118]genomic DNA
 
 
Figure AIII.3. This figure shows the PCR products from PCR reactions on genomic DNA of the excision strains ex1.2/CyO, ex.2.1/ 
CyO and ex. 6.1/ CyO.  Note that ex1.2/ CyO is the same strains as ex1.7/ CyO. The positions of the primers are shown in Figure 
AIII.2. 
 
For this experiment, homozygous ex1.7/ex1.7 or heterozygous ex1.7/CyOactGFP larvae were selected (by the 
absence or presence of GFP) and pooled into groups of four.  Genomic DNA was prepared from each pool 
of four larvae.  Fig AIII.4 shows that in wild type embryos, all 4 genes on the 3 prime side are present.  
However, in ex1.7/ex1.7 homozygotes, CG12340 is missing whereas the other 3 are still present.  Thus the 
excision removes the gene encoding LD26050 but does not extend as far as the predicted gene CG12339.   
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Phenotype of ex1.7 
mAB2a12 staining of ex1.7/CyO x ex1.7/CyO collections showed that the trachea are normal and indicated 
that the tracheal phenotype observed in Df520 and Df596 is not due to the lack of CG12340.  In fact, 
ex1.7/ex1/7 homozygotes only die as pharate adults.  Out of 32 homozygotes (identified by GFP- larvae 
from w;ex1.7/CyOactGFP parents), two even emerged out of their pupal case, but couldnt stand up.  Others 
struggled to emerge from their pupal cases, but failed to emerge. 
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Figure AIII.4   This figure shows the products of PCR reactions on genomic DNA isolated from larvae. 
The position of the primers is shown in Figure AIII.3 
 
Full length CG12340 interaction with Dof∆C 
Since only a third of the CG12340 transcript was isolated in the yeast two-hybrid screen, the full length 
transcript was cloned into the yeast two-hybrid vectors.  The clone 271 contains a fusion of the full length 
protein fused to the activation domain, the clone 272 contains a fusion of the full length protein fused to the 
DNA binding domain.  The full length clone only interacts weakly with Dof∆C in both directions.  It 
should be pointed out that the interaction was observed with i119 in the pACT2 vector, whereas the full 
length fusion constructs were cloned into pGAD and pGBDU (see Appendix I.). 
The clones used to generate the construct 271 (DNA-binding fusion in the vector pGBD) and construct 272 
(activation domain fusion in the vector pGAD) are shown in Table AIII.2. 
 
construct # cloning method 
212 LD26050 (in pOT2 RI/XhoI)  
226 pGBD-C3 NotI- BamHI digest, Klenow fill, NcoI linker NEB 1151 addition 
227 pGAD-C3 NotI-BamHI digest, Klenow fill, NcoI linker NEB 1151 addition 
231 A226 NotI, klenow fill, add AvrII linker 
232 A227 NotI, klenow fill, add AvrII linker 
265 SmaI-SpeI digested PCR fragment *** fromORF LD26050 into SmaI-AvrII A231  
266 SmaI-SpeI digested PCR  fragment*** from ORF LD26050 into SmaI-AvrII A232  
268 A265 shortened with NarI  
269 A266 shortened with NarI  
271 NcoI-SacII A268 + NcoI-SacII A212  
272 NcoI-SacII A269 + NcoI-SacII A212 
 
Table AIII.2 This table describes the intermediate clones used to generate constructs 271 and 272.  ***primers for PCR: p124 
(catcccgggcggccgcatgatgggagtaaaccagac; SmaI site and NotI site in front of ATG) and p125 (gactagtacgaccaggtcttgggaaca; has SpeI 
site)
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Appendix IV:  Constructs 
 
Table IV.1 describes the clones used in this project . 
 
NAME OF 
CONSTRUCT 
CLONING METHOD 
DB-Dof∆C 2.4kb NotI/BglII partial of 1f11 (Dof in pNB40) into BamHI/NotI pGBDU-C2 NotI (from J.Hancke) 
int. JH17  DB-Dof∆C XhoI/NotI cloned into A146 
AD-Dof∆C insert from DB-Dof∆C into pGAD-C2NotI via EcoR1/Not1 (from J.Hancke) 
DB409C DB-Dof∆C  BglII-ClaI gap repair** with NcoI-XhoI of Dof D233-449* 
AD409C AD-Dof∆C BglII-ClaI gap repair** with NcoI-XhoI of Dof D233-449* 
DB403C DB-Dof∆C  BglII-ClaI gap repair** with NcoI-XhoI of DofD361-449* 
AD403C AD-Dof∆C BglII-ClaI gap repair** with NcoI-XhoI of DofD361-449* 
DB430C DB-Dof∆C  BglII-ClaI gap repair** with NcoI-XhoI of DofD233-364* 
AD430C AD-Dof∆C BglII-ClaI gap repair** with NcoI-XhoI of DofD233-364* 
AD341 AD-Dof∆C Ehe-ClaI gap repair** with Sfi I/XhoI of DofDE531* 
AD256 JH14 insert into AD-Dof∆C via NotI-EheI  
DB256 JH14 insert into DB-Dof∆C  via NotI-EheI  
DB426 DofDS89/E802* NcoI-XbaI into A231 NcoI-AvrII  
AD426 DofDS89/E802* NcoI-XbaI into A232 NcoI-AvrII  
DB427 DofDS168/E802* NcoI-XbaI into A231 NcoI-AvrII  
AD427 DofDS168/E802*  NcoI-XbaI into A232 NcoI-AvrII  
DB i21 i21 NcoI-SpeI into A231NcoI-AvrII  
AD i21 i21 NcoI-SpeI into A232NcoI-AvrII  
DB352 DofDS89* NcoI-SpeI into A231NcoI-AvrII  
AD352 DofDS89* NcoI-SpeI into A232NcoI-AvrII  
DB353 DofDS168* NcoI-SpeI into A231NcoI-AvrII  
AD353 DofDS168* NcoI-SpeI into A232NcoI-AvrII  
DB354 DofDS227* NcoI-SpeI into A231NcoI-AvrII  
AD354 DofDS227* NcoI-SpeI into A232NcoI-AvrII  
DBi21-cc i21 XhoI, fill, add NcoI linker, clone NcoI-SpeI fragment into A#231 NcoI-AvrII  
ADi21-cc i21 XhoI, fill, add NcoI linker, clone NcoI-SpeI fragment into A#232 NcoI-AvrII  
AD430  AD256 BglII-ClaI gap repair** with DofD233-364* NcoI-XhoI  
DB430 JH14 EheI-NotI insert into DB430C EheI-NotI  
DB409 JH14 EheI-NotI insert into DB409C EheI-NotI  
AD409 JH14 EheI-NotI insert into DB409C EheI-NotI  
AD403 JH14 EheI-NotI into AD403C EheI-NotI  
DB403 JH14 EheI-NotI insert into DB403C EheI-NotI  
AD405 DofDE453* BglII-XbaI into A261 BglII-AvrII  
DB405 DofDE453*  BglII-XbaI into A262 BglII-AvrII  
AD404 DofDE531* BglII-XbaI into A261 BglII-AvrII  
DB404 DofDE531* BglII-XbaI into A262 BglII-AvrII  
JH15 JH11 EcoRI-NotI into pGBDc1NotI EcoRI-Not (J.Hancke) 
JH11 Clone BglII-Stu>NotI fragment from 1f11 (Dof) into pGAD C2 Not1 BamHI-NotI (from J.Hancke) 
JH14 JH10 EcoRI-Not into pGBDc1NotI EcoRI-NotI (from J.Hancke) 
JH10 2.8kb BglII-NotI from 1f11 (Dof) into pGADc2NotI BamHI-NotI (from J.Hancke) 
JH16 JH13 EcoRI-NotI into pGBDc1-NotI EcoRI-Not (from J.Hancke) 
JH13 JH10 XhoI, blunt, NotI linker,close. BglII-XhoI is 1.58kb (from J.Hancke) 
pGAD-C(x) James et al. 1996 
pGBD-C1 James et al. 1996 
pGBDU-C1 James et al. 1996 
pODB8 Louvet et al. 1997 
pGAD-C1 NotI pGAD-C1 BglII digest, fill-in, NotI linker addition (J.Hancke) 
pGAD-C2 NotI pGAD-C2 BglII digest, fill-in, NotI linker addition (J.Hancke) 
pGAD-C3 NotI pGAD-C3 BglII digest, fill-in, NotI linker addition (J.Hancke) 
pGBD-C3 NotI pGBD-C3 BglII digest, fill-in, NotI linker addition (J.Hancke) 
pGBDU-C2 NotI pGBDU-C2 BglII digest, fill-in,  NotI linker addition (J.Hancke) 
pUASTλBtl gift from D. Montel. Note: the intron in this Breathless cDNA was not spliced out. 
pAlter-1 Promega 
A121 pODB8 BamHI>NotI 
A146 int. pGBDU-C2 NotI (2µ removed by discarding AatII-SnaBI fragment from pGBDU-NotI, blunting, 
then religating) 
A226 pGBD-C3 NotI digested with BamHI, filled, NcoI linker addition (NEB 1151)  
A227 pGAD-C3 NotI digested with BamHI, filled, NcoI linker addition (NEB 1151) 
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NAME OF 
CONSTRUCT 
CLONING METHOD 
A231 A226 NotI, klenow fill, add AvrII linker (NEB#1123) 
A232 A227 NotI, klenow fill, add AvrII linker (NEB#1123) 
A261 AD256 NotI, fill in, add AvrII linker (Neb1123)  
A262 DB256 NotI, fill in, add AvrII linker (Neb1123) 
DB-Btl-K cyt btl in pACT2∆frameI: EcoRI-SalI AD-Btl-K into EcoRI-XhoI A296  
AD-Btl-K cyt btl in pODB8 (EcoRI-BglII A275 into EcoRI-BamHI pODB8) 
A296 NcoI digest A295, fill, close) 
A295  BamHI digest pACT2, fill, close 
A275 XbaI A#273 insert into XbaI A#208.1  
A273 Breathless cDNA without intron. Made by looping the intron out of the Breathless sequence in A267 
using the Altered Sites II in vitro Mutagenesis System (Promega). The mutagenesis primer used was 
5gcttcaagacggtgcattcatcgc 3 
A267 pUASTλBtl NotI into NotI A258  
A258 pAlter-1 SmaI, add NotI linker (NEB#1126) close 
A208.1 BglII-EcoRI digested PCR product from pUASTλBtl (primers 5agagaattcgtggagtatgctccacacg3 and 
5agagagatctaggtgtactgatatctaagc3) into BglII-EcoRI pGAD-C2 . Note: This cDNA contains intron! 
DB-Htl BglII-XbaI of Htl cDNA ( B. Shilo, BglII linker NEB#1052 introduced at XbaI site) into BamHI-
XbaI of A#209 
A307 i8 BamHI digest. Fill (frameshift#1)  
A308 A307 NcoI digest. Fill (frameshift#2) Sequenced. 
DB-∆s.site#3 BsshII-EheI A288 into BsshII-EheI A304 
AD-∆s.site#3 BsshII-EheI A288 into BsshII-EheI A306 
A306 AD-Dof∆C BglII-SfiI. Discard 400bp fragment. blunt. close 
A304 DB-Dof∆C  BglII-SfiI. Discard 400bp fragment. blunt. close 
A288 1f11in pAlter containing mutated sumoylation site#3 in. Made by introducting an Arginine to Lysine 
(aag becomes aga) at third SUMOlation site of Dof using the Altered Sites II in vitro Mutagenesis 
System (Promega). The mutagenesis primer used was 5gacccatcagatgcgaaagtc 3 
1f11in pAlter 1f11+5FLAGTAG in pNB40 into pAlter via EcoRI-SphI . Construct from R. Wilson 
 
Table AIV.1  This table describes the constructs used in this work. Constructs discussed in the results 
section are in bold type. All others are intermediate constructs used for cloning.  **gap repair was 
performed as described by N. Lehming et al. (1995). *All cDNAs with deletions in Dof were obtained from 
R. Wilson 
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Abbreviations 
 
Ade  Adenine 
ATP  Adenosine Triphosphate 
bp  base pairs 
BSA  Bovine Serum Albumin 
cDNA  complementary DNA 
DTT  Dithiothreitol 
EDTA  Ethylene Diamine Tetracetic Acid 
g  gram 
GST  Glutathione-S-transferase 
His  Histidine 
k  kilo 
L  Leucine 
LacZ  beta-galactosidase 
M  mol per liter 
m  milli 
µ  micro 
mRNA  messenger RNA 
n  nano 
NGS  Normal Goat Serum 
PCR  polymerase chain reaction 
RNA  ribonucleic acid 
SC-U  Synthetic Complete medium lacking Uracil 
SC-UL  Synthetic Complete medium lacking Uracil and Leucine 
SC-ULH Synthetic Complete medium lacking Uracil, Leucine and Histidine 
SC-H  Synthetic Complete medium lacking Histidine 
SC-A  Synthetic Complete medium lacking Adenine 
X-Gal  5-Bromo-4chloro-3-indoyl-ß-D-galactoside 
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Abstract 
 
 
Downstream of FGFR (Dof) is an adaptor protein that is required specifically for 
Fibroblast Growth Factor (FGF) signal transduction in Drosophila melanogaster.  
Although Dof has been shown to function upstream of the Ras MAPK pathway it is 
unknown how Dof transduces the FGF signal from the FGF receptor to the Ras MAPK 
pathway.  It is also unclear whether Dof is required for the transduction of additional 
downstream signaling pathways that might be activated by the FGF receptors.  One way 
to resolve this question is to identify the molecules required for Dofs function.  In this 
project, a yeast two-hybrid screen was conducted to identify interacting partners of Dof.  
Eight groups and three single clones tested positive in three different assays employing 
different reporters with different promoters, some more stringent than others.  The most 
stringent assay eliminated about 70% of the candidates. Those  that remained interactors 
in a less stringent assay might represent weak interactions and were therefore also 
investigated.  Three candidates that tested positive for all selection assays provide clues 
to how Dof may be functioning in vivo.  First, the Drosophila FGF receptor Heartless was 
isolated.  Subsequent work showed that the second Drosophila FGF receptor, Breathless, 
also interacts with Dof in the yeast two-hybrid system.  These results suggest that Dof 
might function by binding directly to the receptor.  The second candidate of interest is 
Ubc9, which conjugates SUMO (small ubiquitin-related modifier) moieties onto target 
proteins.  SUMO has been found to regulate protein-protein interactions and/or 
subcellular localization of target proteins.  Dof has four putative SUMOlation sites and 
when the  third putative SUMOlation site was mutated, this completely abolished  
binding of Dof to both FGFRs in the yeast two-hybrid system, indicating that the binding 
affinity of Dof to the FGFRs might be regulated by post-translational SUMOlation.  The 
third candidate of interest from the screen was Dof itself, revealing that Dof can self-
associate.  In order to characterize this homodimerization in more detail, the domains in 
Dof that are responsible for self-association were mapped by co-expressing a panel of 
Dof deletion constructs against each other in the yeast-two hybrid system.  This 
experiment revealed that a region of the N-terminus can bind both to itself and to a region 
in the C-terminus of the molecule.   
The yeast two-hybrid partners reveal that Dof can potentially receive inputs at 
various levels: It could be receiving a signal directly from the FGF receptors and this 
might be dependent on SUMOlation.  In addition, Dof could be using dimerization to 
channel other signaling molecules into a specific pathway and thereby transduce the FGF 
signal. 
 
 
 
 
 
 
 
  ZUSAMMENFASSUNG 
 87
Zusammenfassung 
 
Der Faktor Downstream of FGFR (Dof) ist ein Adaptorprotein, das spezifisch für den 
FGF Signaltransduktionweg in Drosophila melanogaster benötigt wird. Genetische 
Experimente deuten darauf hin, daß Dof stromaufwärts des Ras MAPK 
Signaltransduktionweges arbeitet. Sein genauer Platz im Signalweg und der eigentliche 
Mechanismus, wie Dof das Signal vom aktivierten Rezeptor zur MAPK Kaskade 
weiterleitet, ist allerdings noch nicht bekannt. Ebenfalls unklar ist, ob Dof auch für die 
Signaltransduktion in anderen, vom FGF-Rezeptor aktivierten Signalwegen benötigt 
wird.  Eine Möglichkeit um diese Fragen zu klären, ist die Identifizierung und 
Charakterisierung von Faktoren, die für die Funktionen von Dof gebraucht werden.  Um 
solche Proteine zu finden wurde in der vorliegenden Arbeit ein yeast two-hybrid 
Experiment durchgeführt. Dieses Experiment wurde mit verschiedenen 
Reporterkonstrukten mit unterschiedlich stringenten Promotoren durchgeführt. Der 
stringenteste Promotor reduzierte die Kandidatenanzahl um 70%.  Die Kandidaten, die 
nur unter weniger stringenten Bedingungen Effekte zeigten, wurden als schwache 
Interaktoren klassifiziert und ebenfalls untersucht. Insgesamt acht Gruppen und drei 
einzelne Klone zeigten Interaktion in den drei obengenannten Testsystemen.  Schließlich 
wurden drei Kandidaten ermittelt, die einen Hinweis auf die Wirkungsweise von Dof im 
Drosophila Embryo geben könnten.  
Ein erster Kandidat ist einer der Rezeptoren des FGF Signalweges, Heartless. 
Weiterführende Arbeiten konnten zeigen, dass auch der zweite Rezeptor, Breathless, im 
yeast two-hybrid Experiment mit Dof interagiert.  Diese Ergebnisse deuten darauf hin, 
daß Dof direkt an den Rezeptor bindet und so die Signalweiterleitung steuert. 
Ein zweiter Faktor, der im Rahmen dieser Arbeit identifiziert wurde, ist das 
Protein Ubc9 (Ubiquitin Conjugating Enzyme).  Ubc9 kann einen Ubiquitin verwandten 
Faktor namens SUMO (small ubiquitin-related modifier) auf Zielproteine übertragen. Es 
ist bekannt, daß durch solche Modifikationen Proteininteraktionen und/oder 
Proteinlokalisierungen innerhalb der Zelle, reguliert werden.  Das Dof Protein besitzt vier 
Stellen an denen es möglicherweise mit SUMO verbunden werden könnte. Die Analyse 
der einzelnen Erkennungssequenzen wurde wieder im yeast two-hybrid Ansatz 
durchgeführt. Diese ergab, dass das Dof  mit einer Mutation in der dritten SUMO 
Verknüpfungsstelle nicht mehr mit den beiden FGF Rezeptoren interagieren kann. Die 
Bindung von Dof an die Rezeptoren könnte also durch die Ankopplung von SUMO 
reguliert bzw. ermöglicht werden. 
Der dritte Kandidat ist Dof selber, was vermuten lässt, dass Dof Homodimere 
bilden kann. Um diese Dimerisierung näher zu charakterisiern wurden die dafür 
notwendigen Proteindomänen bestimmt. Hierfür wurden, wieder im yeast two-hybrid 
System, mehrer Deletionskonstrukte in verschiedenen Kombinationen exprimiert. Diese 
Analyse zeigt, dass eine bestimmte Region im N-Terminus des Proteins mit sich selber 
und mit einer c-terminalen Region interagieren kann. 
Die Identifizierung der oben genannten Kandidaten im Rahmen dieser Arbeit, 
zeigt wie vielfältig die Wirkungsweise und Regulation von Dof möglicherweise ist. Eine 
Regulation ist, wie oben gezeigt, sowohl auf der Ebene des Rezeptors, als auch durch 
Modifikationen von Dof selber, entweder durch Dimerisierung oder Verknüpfung mit 
SUMO,denkbar.
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